<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml" xml:lang="en" lang="en">
    
    <head><meta http-equiv="Content-Type" content="text/html; charset=utf-8" />
        <!-- AppResources meta begin -->
        <meta name="paf-app-resources" content="" />
                 <script type="text/javascript">var ncbi_startTime = new Date();</script>
            
        <!-- AppResources meta end -->
        
        <!-- TemplateResources meta begin -->
        <meta name="paf_template" content="" />

        <!-- TemplateResources meta end -->
        
        <!-- Logger begin -->
        <meta name="ncbi_db" content="books" /><meta name="ncbi_pdid" content="book-part" /><meta name="ncbi_acc" content="NBK1356" /><meta name="ncbi_domain" content="gene" /><meta name="ncbi_report" content="record" /><meta name="ncbi_type" content="fulltext" /><meta name="ncbi_objectid" content="" /><meta name="ncbi_pcid" content="/NBK1356/" /><meta name="ncbi_pagename" content="Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related - GeneReviews® - NCBI Bookshelf" /><meta name="ncbi_bookparttype" content="chapter" /><meta name="ncbi_app" content="bookshelf" />
        <!-- Logger end -->
        
        <title>Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related - GeneReviews® - NCBI Bookshelf</title>
        
        <!-- AppResources external_resources begin -->
        <link rel="stylesheet" href="/core/jig/1.14.8/css/jig.min.css" /><script type="text/javascript" src="/core/jig/1.14.8/js/jig.min.js"></script>

        <!-- AppResources external_resources end -->
        
        <!-- Page meta begin -->
        <meta name="robots" content="INDEX,FOLLOW,NOARCHIVE" /><meta name="citation_inbook_title" content="GeneReviews® [Internet]" /><meta name="citation_title" content="Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related" /><meta name="citation_publisher" content="University of Washington, Seattle" /><meta name="citation_date" content="2016/06/30" /><meta name="citation_author" content="Anthony J Bleyer" /><meta name="citation_author" content="P Suzanne Hart" /><meta name="citation_author" content="Stanislav Kmoch" /><meta name="citation_pmid" content="20301530" /><meta name="citation_fulltext_html_url" content="https://www.ncbi.nlm.nih.gov/books/NBK1356/" /><meta name="citation_keywords" content="ADTKD-UMOD" /><meta name="citation_keywords" content="Familial Juvenile Hyperuricemic Nephropathy 1" /><meta name="citation_keywords" content="Medullary Cystic Kidney Disease 2" /><meta name="citation_keywords" content="UMOD-Associated Kidney Disease" /><meta name="citation_keywords" content="Uromodulin Kidney Disease" /><meta name="citation_keywords" content="Medullary Cystic Kidney Disease 2" /><meta name="citation_keywords" content="Familial Juvenile Hyperuricemic Nephropathy 1" /><meta name="citation_keywords" content="UMOD-Associated Kidney Disease" /><meta name="citation_keywords" content="ADTKD-UMOD" /><meta name="citation_keywords" content="Uromodulin Kidney Disease" /><meta name="citation_keywords" content="Uromodulin" /><meta name="citation_keywords" content="UMOD" /><meta name="citation_keywords" content="Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related" /><link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /><meta name="DC.Title" content="Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related" /><meta name="DC.Type" content="Text" /><meta name="DC.Publisher" content="University of Washington, Seattle" /><meta name="DC.Contributor" content="Anthony J Bleyer" /><meta name="DC.Contributor" content="P Suzanne Hart" /><meta name="DC.Contributor" content="Stanislav Kmoch" /><meta name="DC.Date" content="2016/06/30" /><meta name="DC.Identifier" content="https://www.ncbi.nlm.nih.gov/books/NBK1356/" /><meta name="description" content="Autosomal dominant tubulointerstitial kidney disease caused by UMOD pathogenic variants (ADTKD-UMOD) was previously known as familial juvenile hyperuricemic nephropathy type 1 (FJHN1), medullary cystic kidney disease type 2 (MCKD2), and UMOD-associated kidney disease (or uromodulin-associated kidney disease). Typical clinical findings:" /><meta name="og:title" content="Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related" /><meta name="og:type" content="book" /><meta name="og:description" content="Autosomal dominant tubulointerstitial kidney disease caused by UMOD pathogenic variants (ADTKD-UMOD) was previously known as familial juvenile hyperuricemic nephropathy type 1 (FJHN1), medullary cystic kidney disease type 2 (MCKD2), and UMOD-associated kidney disease (or uromodulin-associated kidney disease). Typical clinical findings:" /><meta name="og:url" content="https://www.ncbi.nlm.nih.gov/books/NBK1356/" /><meta name="og:site_name" content="NCBI Bookshelf" /><meta name="og:image" content="https://www.ncbi.nlm.nih.gov/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" /><meta name="twitter:card" content="summary" /><meta name="twitter:site" content="@ncbibooks" /><meta name="bk-non-canon-loc" content="/books/n/gene/mckd2/" /><link rel="canonical" href="https://www.ncbi.nlm.nih.gov/books/NBK1356/" /><link rel="stylesheet" href="/corehtml/pmc/css/figpopup.css" type="text/css" media="screen" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books.min.css" type="text/css" /><link rel="stylesheet" href="/corehtml/pmc/css/bookshelf/2.22/css/books_print.min.css" type="text/css" media="print" /><style type="text/css">p a.figpopup{display:inline !important} .bk_tt {font-family: monospace}  .first-line-outdent .bk_ref {display: inline}  .body-content h2, .body-content .h2  {border-bottom: 1px solid #97B0C8} .body-content h2.inline {border-bottom: none} a.page-toc-label , .jig-ncbismoothscroll a {text-decoration:none;border:0 !important} .temp-labeled-list  .graphic {display:inline-block !important} .temp-labeled-list  img{width:100%}</style><script type="text/javascript" src="/corehtml/pmc/js/jquery.hoverIntent.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/common.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/large-obj-scrollbars.min.js"> </script><script type="text/javascript">window.name="mainwindow";</script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/book-toc.min.js"> </script><script type="text/javascript" src="/corehtml/pmc/js/bookshelf/2.22/books.min.js"> </script><meta name="book-collection" content="NONE" />

        <!-- Page meta end -->
    <link rel="shortcut icon" href="//www.ncbi.nlm.nih.gov/favicon.ico" /><meta name="ncbi_phid" content="CE8BED70E0418A710000000008A6033F.m_12" />
<meta name='referrer' content='origin-when-cross-origin'/><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3852956/3985586/3808861/4121862/3974050/3917732/251717/4098876/14534/45193/4113719/3849091/3984811/3751656/4033350/3840896/3577051/3852958/4008682/3881636/3579733/4062871/12930/3964959/3854974/36029/4128070/9685/3549676/3609192/3609193/3609213/3395586.css" /><link type="text/css" rel="stylesheet" href="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/css/3411343/3882866.css" media="print" /></head>
    <body class="book-part">
        <div class="grid">
            <div class="col twelve_col nomargin shadow">
                <!-- System messages like service outage or JS required; this is handled by the TemplateResources portlet -->
                <div class="sysmessages">
                    <noscript>
	<p class="nojs">
	<strong>Warning:</strong>
	The NCBI web site requires JavaScript to function. 
	<a href="/guide/browsers/#enablejs" title="Learn how to enable JavaScript" target="_blank">more...</a>
	</p>
	</noscript>
                </div>
                <!--/.sysmessage-->
                <div class="wrap">
                    <div class="page">
                        <div class="top">
                            <div class="universal_header" id="universal_header"><ul class="inline_list jig-ncbimenu ui-ncbimenu resources_list" id="navcontent"><li class="ui-ncbimenu-item-leaf ui-ncbimenu-item-first ui-helper-reset ui-ncbimenu-item-no-hlt"><a class="ui-ncbimenu-link-first" href="/" role="banner" title="NCBI Home" id="ncbihome" accesskey="1"><span class="offscreen_noflow">NCBI</span><img src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/img/28977" class="ncbi_logo" title="NCBI" alt="NCBI Logo" /></a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#maincontent" title="Skip to the content" tabindex="0" accesskey="3">Skip to main
                        content</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="#navcontent" title="Skip to the navigation" tabindex="0" accesskey="4">Skip to
                        navigation</a></li><li id="resource-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first ui-helper-reset"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#resources">Resources</a></li><li id="all-howtos-menu" class="topmenu ui-helper-reset ui-ncbimenu-item-first"><a class="ui-ncbimenu-first-link-has-submenu ui-ncbimenu-link-first topanchor expandDown" href="/static/header_footer_ajax/submenu/#howto">How To</a></li><li class="offscreen_noflow ui-ncbimenu-item-skip access"><a href="/guide/browsers/#accesskeys" title="About My NCBI Accesskeys" tabindex="0" accesskey="0">About NCBI Accesskeys</a></li></ul><div class="myncbi"><span id="myncbiusername" style="display:none"><a href="/account/settings/" id="mnu" title="Edit account settings"></a></span><a accesskey="2" href="/myncbi/" id="myncbi" style="display:none">My NCBI</a><a href="/account/" id="sign_in">Sign in to NCBI</a><a href="/account/signout/" id="sign_out" style="display:none">Sign Out</a></div></div>
                            <div class="header">
    <div class="res_logo"><h1 class="res_name"><a href="/books/" title="Bookshelf home">Bookshelf</a></h1><h2 class="res_tagline"></h2></div>
    <div class="search"><form method="get" action="/books/"><div class="search_form"><label for="database" class="offscreen_noflow">Search database</label><select id="database"><optgroup label="Recent"><option value="books" selected="selected" class="last" data-ac_dict="bookshelf-search">Books</option></optgroup><optgroup label="All"><option value="gquery">All Databases</option><option value="assembly">Assembly</option><option value="biocollections">Biocollections</option><option value="bioproject">BioProject</option><option value="biosample">BioSample</option><option value="biosystems">BioSystems</option><option value="books" data-ac_dict="bookshelf-search">Books</option><option value="clinvar">ClinVar</option><option value="cdd">Conserved Domains</option><option value="gap">dbGaP</option><option value="dbvar">dbVar</option><option value="gene">Gene</option><option value="genome">Genome</option><option value="gds">GEO DataSets</option><option value="geoprofiles">GEO Profiles</option><option value="gtr">GTR</option><option value="homologene">HomoloGene</option><option value="ipg">Identical Protein Groups</option><option value="medgen">MedGen</option><option value="mesh">MeSH</option><option value="ncbisearch">NCBI Web Site</option><option value="nlmcatalog">NLM Catalog</option><option value="nuccore">Nucleotide</option><option value="omim">OMIM</option><option value="pmc">PMC</option><option value="popset">PopSet</option><option value="probe">Probe</option><option value="protein">Protein</option><option value="proteinclusters">Protein Clusters</option><option value="pcassay">PubChem BioAssay</option><option value="pccompound">PubChem Compound</option><option value="pcsubstance">PubChem Substance</option><option value="pubmed">PubMed</option><option value="snp">SNP</option><option value="sparcle">Sparcle</option><option value="sra">SRA</option><option value="structure">Structure</option><option value="taxonomy">Taxonomy</option><option value="toolkit">ToolKit</option><option value="toolkitall">ToolKitAll</option><option value="toolkitbookgh">ToolKitBookgh</option></optgroup></select><div class="nowrap"><label for="term" class="offscreen_noflow" accesskey="/">Search term</label><div class="nowrap"><input type="text" name="term" id="term" title="Search Books. Use up and down arrows to choose an item from the autocomplete." value="" class="jig-ncbiclearbutton jig-ncbiautocomplete" data-jigconfig="dictionary:'bookshelf-search',disableUrl:'NcbiSearchBarAutoComplCtrl'" autocomplete="off" data-sbconfig="ds:'no',pjs:'no',afs:'no'" /></div><button id="search" type="submit" class="button_search nowrap" cmd="go">Search</button></div></div></form><ul class="searchlinks inline_list"><li>
                        <a href="/books/browse/">Browse Titles</a>
                    </li><li>
                        <a href="/books/advanced/">Advanced</a>
                    </li><li class="help">
                        <a href="/books/NBK3833/">Help</a>
                    </li></ul></div>
</div>

                            
                            
                        <!--<component id="Page" label="headcontent"/>-->
                            
                        </div>
                        <div class="content">
                            <!-- site messages -->
                            <!-- Custom content 1 -->
<div class="col1">
    
</div>

<div class="container">
    <div id="maincontent" class="content eight_col col">
        <!-- Custom content in the left column above book nav -->
        <div class="col2">
            
        </div>
        
        <!-- Book content -->
        

        <!-- Custom content between navigation and content -->
        <div class="col3">
            
        </div>
        
        <div class="document">
            <div class="pre-content"><div><div class="bk_prnt"><p class="small">NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.</p><p>Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. </p></div><div class="iconblock clearfix whole_rhythm no_top_margin bk_noprnt"><a class="img_link icnblk_img" title="All GeneReviews" href="/books/n/gene/"><img class="source-thumb" src="/corehtml/pmc/pmcgifs/bookshelf/thumbs/th-gene-lrg.png" alt="Cover of GeneReviews®" height="100px" width="80px" /></a><div class="icnblk_cntnt eight_col"><h2>GeneReviews<sup>®</sup> [Internet].</h2><a data-jig="ncbitoggler" href="#__NBK1356_dtls__">Show details</a><div style="display:none" class="ui-widget" id="__NBK1356_dtls__"><div>Adam MP, Ardinger HH, Pagon RA, et al., editors.</div><div>Seattle (WA): <a href="http://www.washington.edu" ref="pagearea=page-banner&amp;targetsite=external&amp;targetcat=link&amp;targettype=publisher">University of Washington, Seattle</a>; 1993-2019.</div></div><div class="half_rhythm"><ul class="inline_list"><li style="margin-right:1em"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a></li></ul></div><div class="bk_noprnt"><form method="get" action="/books/n/gene/" id="bk_srch"><div class="bk_search"><label for="bk_term" class="offscreen_noflow">Search term</label><input type="text" title="Search GeneReviews" id="bk_term" name="term" value="" data-jig="ncbiclearbutton" /> <input type="submit" class="jig-ncbibutton" value="Search GeneReviews" submit="false" style="padding: 0.1em 0.4em;" /></div></form><div><ul class="inline_list"><li><a href="/books/n/gene/advanced/">GeneReviews Advanced Search</a></li><li style="margin-left:.5em"><a href="/books/n/gene/helpadvsearch/">Help</a></li></ul></div></div></div><div class="icnblk_cntnt two_col"><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hyper-nfj2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/li-ar/" title="Next page in this title">Next &gt;</a></div></div></div></div></div>
            <div class="main-content lit-style" itemscope="itemscope" itemtype="http://schema.org/CreativeWork"><div class="meta-content fm-sec"><h1 id="_NBK1356_"><span class="title" itemprop="name">Autosomal Dominant Tubulointerstitial Kidney Disease<i>, UMOD</i>-Related</span></h1><div itemprop="alternativeHeadline" class="subtitle whole_rhythm">Synonyms: ADTKD-<i>UMOD</i>, Familial Juvenile Hyperuricemic Nephropathy 1, Medullary Cystic Kidney Disease 2, <i>UMOD</i>-Associated Kidney Disease, Uromodulin Kidney Disease</div><p class="contrib-group"><span itemprop="author">Anthony J Bleyer</span>, MD, MS, <span itemprop="author">P Suzanne Hart</span>, PhD, and <span itemprop="author">Stanislav Kmoch</span>, PhD.</p><a data-jig="ncbitoggler" href="#__NBK1356_ai__" style="border:0;text-decoration:none">Author Information</a><div style="display:none" class="ui-widget" id="__NBK1356_ai__"><div class="contrib half_rhythm"><span itemprop="author">Anthony J Bleyer</span>, MD, MS<div class="affiliation small">Section on Nephrology<br />Wake Forest University School of Medicine<br />Winston-Salem, North Carolina<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="ude.cmbufw@reyelba" class="oemail">ude.cmbufw@reyelba</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">P Suzanne Hart</span>, PhD<div class="affiliation small">Office of the Clinical Director<br />National Human Genome Research Institute<br />National Institutes of Health<br />Bethesda, Maryland<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="vog.hin.liam@trahs" class="oemail">vog.hin.liam@trahs</a></div></div></div><div class="contrib half_rhythm"><span itemprop="author">Stanislav Kmoch</span>, PhD<div class="affiliation small">Institute for Inherited Metabolic Disorders<br />First Faculty of Medicine<br />Charles University<br />Prague, Czech Republic<div><span class="email-label">Email: </span><a href="mailto:dev@null" data-email="zc.inuc.1fl@hcomks" class="oemail">zc.inuc.1fl@hcomks</a></div></div></div></div><p class="small">Initial Posting: <span itemprop="datePublished">January 12, 2007</span>; Last Update: <span itemprop="dateModified">June 30, 2016</span>.</p><p><em>Estimated reading time: 22 minutes</em></p></div><div class="jig-ncbiinpagenav body-content whole_rhythm" data-jigconfig="allHeadingLevels: ['h2'],smoothScroll: false" itemprop="text"><div id="mckd2.Summary" itemprop="description"><h2 id="_mckd2_Summary_">Summary</h2><div><h4 class="inline">Clinical characteristics.</h4><p>Autosomal dominant tubulointerstitial kidney disease caused by <i>UMOD</i> pathogenic variants (ADTKD-<i>UMOD</i>) was previously known as <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> juvenile hyperuricemic nephropathy type 1 (FJHN1), medullary cystic kidney disease type 2 (MCKD2), and <i>UMOD</i>-associated kidney disease (or uromodulin-associated kidney disease). Typical clinical findings:</p><ul><li class="half_rhythm"><div>Urinalysis revealing minimal protein and no blood</div></li><li class="half_rhythm"><div>Slowly progressive chronic kidney failure, usually first noted in the teen years and progressing to end-stage renal disease (ESRD) between the fourth and seventh decades (Age at ESRD varies among and within families.)</div></li><li class="half_rhythm"><div>Hyperuricemia and gout (resulting from reduced kidney excretion of uric acid) that occurs as early as the teenage years</div></li></ul></div><div><h4 class="inline">Diagnosis/testing.</h4><p>ADTKD-<i>UMOD</i> is defined by the presence of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>UMOD</i>, the <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> encoding uromodulin. The majority of persons with ADTKD-<i>UMOD</i> have the following laboratory test abnormalities: elevated serum creatinine (decreased estimated glomerular filtration rate), bland urinary sediment, elevated serum urate level, and reduced fractional excretion of uric acid. In children with the disorder, serum creatinine levels may be normal but elevated serum urate levels are usually present.</p></div><div><h4 class="inline">Management.</h4><p><i>Treatment of manifestations</i>: Allopurinol or probenecid for prevention of gout; referral to a nephrologist to monitor kidney function, evaluate for manifestations of chronic kidney disease, and prepare for renal replacement therapy. Hemodialysis and peritoneal dialysis can replace renal function; kidney transplantation is curative.</p><p><i>Prevention of primary manifestations</i>: Allopurinol, febuxostat, or probenecid lowers high serum urate levels effectively and will prevent development of gout.</p><p><i>Surveillance</i>: Measurement of serum concentration of creatinine and uric acid at least annually.</p><p><i>Agents/circumstances to avoid</i>: Drugs known to be nephrotoxic; volume depletion and dehydration; high meat and seafood intake (may exacerbate hyperuricemia/gout).</p><p><i>Evaluation of relatives at risk</i>: If the causative <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, offer <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> to at-risk relatives, particularly: (1) adolescents because of the benefit of allopurinol administration for the prevention of gout; (2) potential kidney donors.</p><p><i>Pregnancy management</i>: Allopurinol should be discontinued in women who are pregnant or who may become pregnant. Women taking an angiotensin-converting enzyme inhibitor and who are pregnant or may become pregnant should transition to another antihypertensive medication. Ideally women should not be taking either allopurinol or an ACE inhibitor during pregnancy.</p></div><div><h4 class="inline">Genetic counseling.</h4><p>ADTKD-<i>UMOD</i> is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner. Most individuals diagnosed with ADTKD-<i>UMOD</i> have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent. Each child of an affected individual has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Prenatal testing is possible for pregnancies at increased risk in families in which the pathogenic variant has been identified.</p></div></div><div id="mckd2.Diagnosis"><h2 id="_mckd2_Diagnosis_">Diagnosis</h2><div id="mckd2.Suggestive_Findings"><h3>Suggestive Findings</h3><p>Autosomal dominant tubulointerstitial kidney disease, <i>UMOD</i>-related (ADTKD-<i>UMOD</i>) <b>should be suspected</b> in individuals with the following findings:</p><p><b>Clinical</b></p><ul><li class="half_rhythm"><div><b>Tubulointerstitial kidney disease.</b> Urinalysis of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals reveals few or no red cells or white cells, and &#x0003c;500 mg of urinary protein.</div></li><li class="half_rhythm"><div><b>Slowly progressive chronic kidney disease.</b> Affected individuals usually develop asymptomatic elevations in their serum creatinine concentration between ages ten and 40 years, although asymptomatic elevations may occur at a younger age [<a class="bk_pop" href="#mckd2.REF.sch_ffer.2010.1355">Sch&#x000e4;ffer et al 2010</a>]. End-stage renal disease (ESRD) usually develops in the fourth to seventh decade of life [<a class="bk_pop" href="#mckd2.REF.bleyer.2003.36">Bleyer et al 2003</a>].</div></li><li class="half_rhythm"><div><b>Hyperuricemia and gout,</b> found in most (not all) <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals. Elevated serum uric acid concentrations are usually present in childhood and often result in gout in the teen years, especially in young men, though it also can occur in women [<a class="bk_pop" href="#mckd2.REF.bleyer.2003.36">Bleyer et al 2003</a>]. Some families have milder forms of disease, and in these families, gout may be uncommon or absent in family members [<a class="bk_pop" href="#mckd2.REF.smith.2011.2766">Smith et al 2011</a>].</div></li><li class="half_rhythm"><div><b>Autosomal dominant inheritance.</b> The presence of chronic kidney disease (elevated serum creatinine) or ESRD inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner is another important clue to this disorder.</div></li></ul><div id="mckd2.Testing"><h4>Testing</h4><p>The majority of persons with ADTKD-<i>UMOD</i> have the following laboratory test abnormalities: elevated serum creatinine (decreased estimated glomerular filtration rate), bland urinary sediment, elevated serum urate level, and reduced fractional excretion of uric acid. In children with the disorder, serum creatinine levels may be normal but elevated serum urate levels are usually present.</p><p><b>Serum creatinine (eGFR</b>)<b>.</b> As individuals with ADTKD-<i>UMOD</i> age, kidney function worsens, and the serum creatinine rises.</p><ul><li class="half_rhythm"><div class="half_rhythm">The serum creatinine is an indirect measure of glomerular filtration rate, and there are formulas that calculate the estimated glomerular filtration rate from the serum creatinine.</div><div class="half_rhythm">Note: On most laboratory reports, the estimated glomerular filtration rate is included. However, calculators for this purpose are available online (see, e.g., <a href="http://www.mdcalc.com/mdrd-gfr-equation/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.mdcalc.com</a>).</div></li><li class="half_rhythm"><div class="half_rhythm">A reduced eGFR (&#x0003c;90 mL/min/1.73 m<sup>2</sup>) is a sensitive indicator of ADTKD-<i>UMOD</i> in adults, but it is not specific, as many individuals in the general population have mildly decreased eGFR measurements.</div></li><li class="half_rhythm"><div class="half_rhythm">The lower the eGFR in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, the more likely it is to indicate ADTKD-UMOD: very few individuals in the general population have an eGFR &#x0003c;60 mL/min/1.73 m<sup>2</sup>.</div></li></ul><p><b>Urinalysis.</b> In almost all individuals with ADTKD-<i>UMOD</i>, the urinary sediment is bland, with &#x0003c;3 red blood cells/high power field and urinary protein on dipstick negative or 1+.</p><ul><li class="half_rhythm"><div>A 24-hour urinary collection yields &#x0003c;500 grams protein/24 hours.</div></li><li class="half_rhythm"><div>A spot urinary protein:creatinine ratio will be &#x0003c;500 mg protein/g creatinine.</div></li><li class="half_rhythm"><div>Rarely, in advanced kidney disease, the urinary protein may be increased.</div></li></ul><p><b>Serum concentration of uric acid.</b> Hyperuricemia (serum uric acid concentration &#x0003e;6 mg/dL) is present in the vast majority of individuals with ADTKD-<i>UMOD</i>, even prior to the development of kidney failure.</p><ul><li class="half_rhythm"><div>In children, hyperuricemia is more likely to be present than an elevated serum creatinine concentration.</div></li><li class="half_rhythm"><div>Usually, hyperuricemia in an individual with normal kidney function corresponds to a serum concentration of uric acid &#x0003e;1 SD above the normal value for age and sex.</div></li></ul><p>Note: It is important to compare the serum uric acid concentration with age- and gender-specific normal values (see <a class="figpopup" href="/books/NBK1356/table/mckd2.T.serum_uric_acid_concentration_in/?report=objectonly" target="object" rid-figpopup="figmckd2Tserumuricacidconcentrationin" rid-ob="figobmckd2Tserumuricacidconcentrationin">Table 1</a>) [<a class="bk_pop" href="#mckd2.REF.wilcox.1996.731">Wilcox 1996</a>].</p><div id="mckd2.T.serum_uric_acid_concentration_in" class="table"><h3><span class="label">Table 1. </span></h3><div class="caption"><p>Serum Uric Acid Concentration in Individuals with Normal Renal Function</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1356/table/mckd2.T.serum_uric_acid_concentration_in/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mckd2.T.serum_uric_acid_concentration_in_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" rowspan="2" scope="col" colspan="1" headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" style="text-align:left;vertical-align:middle;">Age</th><th id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2" colspan="2" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Serum Concentration (mg/dL)</th></tr><tr><th headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2" id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" colspan="1" scope="colgroup" rowspan="1" style="text-align:left;vertical-align:middle;">Males</th><th headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2" id="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Females</th></tr></thead><tbody><tr><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003c;5 years</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:center;vertical-align:middle;">3.6&#x000b1;0.9</td></tr><tr><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5-10 years</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" colspan="2" rowspan="1" style="text-align:center;vertical-align:middle;">4.1&#x000b1;1.0</td></tr><tr><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12 years</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.4&#x000b1;1.1</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.5&#x000b1;0.9</td></tr><tr><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15 years</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.6&#x000b1;1.1</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.5&#x000b1;0.9</td></tr><tr><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;18 years</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_1" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6.2&#x000b1;0.8</td><td headers="hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_1_2 hd_h_mckd2.T.serum_uric_acid_concentration_in_1_1_2_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.0&#x000b1;0.7</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#mckd2.REF.mikkelsen.1965.242">Mikkelsen et al [1965]</a>, <a class="bk_pop" href="#mckd2.REF.harkness.1969.773">Harkness &#x00026; Nicol [1969]</a>, <a class="bk_pop" href="#mckd2.REF.wilcox.1996.731">Wilcox [1996]</a></p></div></dd></dl></div></div></div><p><b>Fractional excretion of urinary uric acid</b> is usually decreased in ADTKD-<i>UMOD</i> [<a class="bk_pop" href="#mckd2.REF.moro.1991.263">Moro et al 1991</a>].</p><p>The fractional excretion of urinary uric acid can be calculated as shown:</p><div id="mckd2.Tc" class="table"><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1356/table/mckd2.Tc/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mckd2.Tc_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">Urinary uric acid c. <b>x</b> serum creatinine c. <b>&#x000f7;</b> serum uric acid c. <b>x</b> urine creatinine c.</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">c. = concentration</p></div></dd></dl></div></div></div><p>In ADTKD-<i>UMOD</i>, the fractional excretion of uric acid is usually &#x0003c;5% in adult men and &#x0003c;6% in adult women. The reduction of urate excretion is an early event since it can be detected in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> children with preserved renal function [<a class="bk_pop" href="#mckd2.REF.moro.1991.263">Moro et al 1991</a>, <a class="bk_pop" href="#mckd2.REF.mcbride.1998.357">McBride et al 1998</a>].</p><p>Note: (1) The fractional excretion of urinary uric acid can be measured from a spot urine sample; however, a 24-hour urine collection is preferable. (2) Aspirin, diuretics, and nonsteroidal agents should be avoided during the collection. (3) Because the fractional excretion of uric acid rises above 5% as renal function worsens, this test is not sensitive in individuals with ADTKD-<i>UMOD</i> who have an estimated glomerular filtration rate &#x0003c;70 mL/min.</p><p><a class="figpopup" href="/books/NBK1356/table/mckd2.T.fractional_excretion_of_urinary/?report=objectonly" target="object" rid-figpopup="figmckd2Tfractionalexcretionofurinary" rid-ob="figobmckd2Tfractionalexcretionofurinary">Table 2</a> provides the reference ranges by age in individuals with normal kidney function. A fractional excretion of urate &#x0003e;1 SD below the mean suggests reduced urate excretion.</p><div id="mckd2.T.fractional_excretion_of_urinary" class="table"><h3><span class="label">Table 2. </span></h3><div class="caption"><p>Fractional Excretion of Urinary Uric Acid in Individuals with Normal Renal Function</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1356/table/mckd2.T.fractional_excretion_of_urinary/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mckd2.T.fractional_excretion_of_urinary_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Age (Gender)</th><th id="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Mean (%)</th><th id="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Standard Deviation</th></tr></thead><tbody><tr><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">0-6 weeks</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">29.1</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">11.7</td></tr><tr><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6 weeks - 1 year</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">23.9</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10.4</td></tr><tr><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">1-3 years</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">15.2</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">6.2</td></tr><tr><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3-13 years</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">12.2</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">5.5</td></tr><tr><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;13 years (male)</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">8.0</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">3.7</td></tr><tr><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;13 years (female)</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">10.3</td><td headers="hd_h_mckd2.T.fractional_excretion_of_urinary_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">4.2</td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin"><a class="bk_pop" href="#mckd2.REF.stib_rkov_.2006.1301">Stib&#x0016f;rkov&#x000e1; et al [2006]</a></p></div></dd></dl></div></div></div><p><b>Kidney imaging and histology</b></p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Renal ultrasound examination</b> usually reveals normal kidneys. With more advanced disease, small kidneys may be seen. The ultrasound is not helpful in making the diagnosis of ADTKD-<i>UMOD</i>, except for ruling out polycystic kidney disease or other conditions as a cause of kidney failure.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>Kidney biopsy.</b> Histologic examination shows chronic interstitial fibrosis, with focal tubular atrophy and interstitial fibrosis, occasionally accompanied by lymphocytic infiltration. The main lesions include tubular basement membrane disintegration (thickening and attenuation) and medullary cyst formation in distal tubules and collecting ducts [<a class="bk_pop" href="#mckd2.REF.simmonds.1980.176">Simmonds et al 1980</a>, <a class="bk_pop" href="#mckd2.REF.richmond.1981.163">Richmond et al 1981</a>, <a class="bk_pop" href="#mckd2.REF.gagnadoux.1989.50">Gagnadoux et al 1989</a>, <a class="bk_pop" href="#mckd2.REF.puig.1993.357">Puig et al 1993</a>, <a class="bk_pop" href="#mckd2.REF.dahan.2001.2348">Dahan et al 2001</a>].</div><div class="half_rhythm">Note: (1) Biopsy interpretation may be misleading: many pathologists focus on glomerular changes (which are secondary) and may make the incorrect diagnosis of focal glomerulosclerosis [<a class="bk_pop" href="#mckd2.REF.bleyer.2005.824">Bleyer et al 2005</a>]. (2) Kidney biopsy should <b>not</b> be performed to establish a diagnosis of ADTKD-<i>UMOD</i> because it is an invasive procedure with some risk; and pathologic findings are too nonspecific to reliably identify the causative disorder.</div></li></ul></div></div><div id="mckd2.Establishing_the_Diagnosis"><h3>Establishing the Diagnosis</h3><p>The diagnosis of ADTKD-<i>UMOD</i>
<b>is established</b> in a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> by identification of a <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>UMOD</i> by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> (see <a class="figpopup" href="/books/NBK1356/table/mckd2.T.molecular_genetic_testing_used_i/?report=objectonly" target="object" rid-figpopup="figmckd2Tmoleculargenetictestingusedi" rid-ob="figobmckd2Tmoleculargenetictestingusedi">Table 3</a>).</p><p>Molecular testing approaches can include <b>single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing</b>, use of a <b><a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b>, and <b>more comprehensive</b>
<b><a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b>:</p><ul><li class="half_rhythm"><div class="half_rhythm"><b>Single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing.</b> Full <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> of <i>UMOD</i> has identified all causative pathogenic variants in ADTKD-<i>UMOD</i>. Since ADTKD-<i>UMOD</i> occurs through a <a class="def" href="/books/n/gene/glossary/def-item/gain-of-function/">gain-of-function</a> mechanism and large intragenic <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> or <a class="def" href="/books/n/gene/glossary/def-item/duplication/">duplication</a> has not been reported, testing for intragenic deletions or duplication is unlikely to identify a disease-causing variant.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>A <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a></b> that includes <i>UMOD</i> and other genes of interest (see <a href="#mckd2.Differential_Diagnosis">Differential Diagnosis</a>) may also be considered. Note: (1) The genes included in the panel and the diagnostic <a class="def" href="/books/n/gene/glossary/def-item/sensitivity/">sensitivity</a> of the testing used for each <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> vary by laboratory and are likely to change over time. (2) Some multigene panels may include genes not associated with the condition discussed in this <i>GeneReview</i>; thus, clinicians need to determine which multigene panel is most likely to identify the genetic cause of the condition at the most reasonable cost while limiting identification of variants of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a> and pathogenic variants in genes that do not explain the underlying <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. (3) In some laboratories, panel options may include a custom laboratory-designed panel and/or custom phenotype-focused <a class="def" href="/books/n/gene/glossary/def-item/exome/">exome</a> analysis that includes genes specified by the clinician. (4) Methods used in a panel may include <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a>, <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>, and/or other non-sequencing-based tests.</div><div class="half_rhythm">For an introduction to multigene panels click <a href="/books/n/gene/app5/#app5.Multigene_Panels">here</a>. More detailed information for clinicians ordering genetic tests can be found <a href="/books/n/gene/app5/#app5.Multigene_Panels_FAQs">here</a>.</div></li><li class="half_rhythm"><div class="half_rhythm"><b>More comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing</b> (when available) including <a class="def" href="/books/n/gene/glossary/def-item/exome-sequencing/">exome sequencing</a> and <a class="def" href="/books/n/gene/glossary/def-item/genome-sequencing/">genome sequencing</a> may be considered if serial single-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> testing (and/or use of a <a class="def" href="/books/n/gene/glossary/def-item/multigene-panel/">multigene panel</a> that includes <i>UMOD</i>) fails to confirm a diagnosis in an individual with features of ADTKD-<i>UMOD</i>. Such testing may provide or suggest a diagnosis not previously considered (e.g., mutation of a different gene that results in a similar clinical presentation).</div><div class="half_rhythm">For an introduction to comprehensive <a class="def" href="/books/n/gene/glossary/def-item/genomic/">genomic</a> testing click <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing">here</a>. More detailed information for clinicians ordering genomic testing can be found <a href="/books/n/gene/app5/#app5.Comprehensive_Genomic_Testing_1">here</a>.</div></li></ul><div id="mckd2.T.molecular_genetic_testing_used_i" class="table"><h3><span class="label">Table 3. </span></h3><div class="caption"><p>Molecular Genetic Testing Used in ADTKD-<i>UMOD</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1356/table/mckd2.T.molecular_genetic_testing_used_i/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mckd2.T.molecular_genetic_testing_used_i_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Gene&#x000a0;<sup>1</sup></th><th id="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Test Method</th><th id="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Proportion of Probands with a Pathogenic Variant&#x000a0;<sup>2</sup> Detectable by This Method</th></tr></thead><tbody><tr><td headers="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_1" rowspan="2" scope="row" colspan="1" style="text-align:left;vertical-align:middle;"><i>UMOD</i></td><td headers="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Sequence analysis&#x000a0;<sup>3</sup></td><td headers="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">&#x0003e;95%&#x000a0;<sup>4</sup></td></tr><tr><td headers="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_2" colspan="1" scope="row" rowspan="1" style="text-align:left;vertical-align:middle;">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a>&#x000a0;<sup>5</sup></td><td headers="hd_h_mckd2.T.molecular_genetic_testing_used_i_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Unknown; none reported&#x000a0;<sup>6</sup></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt>1. </dt><dd><div id="mckd2.TF.3.1"><p class="no_margin">See <a href="/books/NBK1356/#mckd2.molgen.TA">Table A. Genes and Databases</a> for <a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> and protein.</p></div></dd><dt>2. </dt><dd><div id="mckd2.TF.3.2"><p class="no_margin">See <a href="#mckd2.Molecular_Genetics">Molecular Genetics</a> for information on allelic variants detected in this <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>.</p></div></dd><dt>3. </dt><dd><div id="mckd2.TF.3.3"><p class="no_margin">Sequence analysis detects variants that are benign, likely benign, of <a class="def" href="/books/n/gene/glossary/def-item/uncertain-significance/">uncertain significance</a>, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a>, <a class="def" href="/books/n/gene/glossary/def-item/nonsense-variant/">nonsense</a>, and <a class="def" href="/books/n/gene/glossary/def-item/splice-site/">splice site</a> variants; typically, <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions/duplications are not detected. For issues to consider in interpretation of <a class="def" href="/books/n/gene/glossary/def-item/sequence-analysis/">sequence analysis</a> results, click <a href="/books/n/gene/app2/">here</a>.</p></div></dd><dt>4. </dt><dd><div id="mckd2.TF.3.4"><p class="no_margin">Pathogenic variants in <i>UMOD</i> have been identified in exons 3, 4, 5, and 7 [<a class="bk_pop" href="#mckd2.REF.williams.2009.2963">Williams et al 2009</a>]. Most variants are identified in exons 3 and 4. It is important to determine whether a diagnostic laboratory sequences all <i>UMOD</i> coding exons or only select exons, which may miss pathogenic variants in other exons. See <a href="#mckd2.Molecular_Pathogenesis">Molecular Pathogenesis</a> regarding <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> numbering of <i>UMOD</i>.</p></div></dd><dt>5. </dt><dd><div id="mckd2.TF.3.5"><p class="no_margin">Gene-targeted <a class="def" href="/books/n/gene/glossary/def-item/deletion-duplication-analysis/">deletion/duplication analysis</a> detects intragenic deletions or duplications. Methods used may include <a class="def" href="/books/n/gene/glossary/def-item/quantitative-pcr/">quantitative PCR</a>, long-range PCR, multiplex ligation-dependent probe amplification (MLPA), and a <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a>-targeted microarray designed to detect single-<a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> deletions or duplications.</p></div></dd><dt>6. </dt><dd><div id="mckd2.TF.3.6"><p class="no_margin">No <a class="def" href="/books/n/gene/glossary/def-item/exon/">exon</a> or whole-<a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> deletions or duplications have been reported as a cause of ADTKD-<i>UMOD</i>. This type of <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> would be an unlikely cause of this condition; thus, the clinical utility of such testing is unknown.</p></div></dd></dl></div></div></div></div></div><div id="mckd2.Clinical_Characteristics"><h2 id="_mckd2_Clinical_Characteristics_">Clinical Characteristics</h2><div id="mckd2.Clinical_Description"><h3>Clinical Description</h3><p>The initial presenting feature is either chronic tubulointerstial kidney disease (elevated serum creatinine) or gout.</p><p><b>Slowly progressive chronic tubulointerstitial kidney disease.</b> Most commonly, the presenting sign is an elevated serum creatinine in a patient with a family history of kidney disease. A mild elevation in serum creatinine may occur in childhood and is usually incidentally noted on laboratory testing for other reasons or when screening is performed in children of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual.</p><ul><li class="half_rhythm"><div>The chronic tubulointerstitial kidney disease of ADTKD-<i>UMOD</i> usually leads to end-stage renal disease (ESRD) between the fourth and seventh decades of life, although renal disease can progress to ESRD before age 30 years [<a class="bk_pop" href="#mckd2.REF.simmonds.1980.176">Simmonds et al 1980</a>, <a class="bk_pop" href="#mckd2.REF.richmond.1981.163">Richmond et al 1981</a>, <a class="bk_pop" href="#mckd2.REF.cameron.1993.105">Cameron et al 1993</a>, <a class="bk_pop" href="#mckd2.REF.puig.1993.357">Puig et al 1993</a>]. The age at ESRD varies both between and within families.</div></li><li class="half_rhythm"><div>Symptoms of ESRD include loss of appetite, nausea, cold intolerance, and fatigue. The age at ESRD varies both among and within families. For example, three <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals in one family had ESRD between age 46 and 50 years, whereas two others did not need renal replacement therapy at ages 56 and 63 years [<a class="bk_pop" href="#mckd2.REF.puig.1993.357">Puig et al 1993</a>].</div></li><li class="half_rhythm"><div>Unlike most other kidney diseases, hypertension frequently does not occur in ADTKD-<i>UMOD</i>.</div></li></ul><p><b>Gout.</b> A history of gout is recorded in only 45% of individuals with a <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, with onset ranging from ages eight to 38 years [<a class="bk_pop" href="#mckd2.REF.dahan.2003.2883">Dahan et al 2003</a>].</p><ul><li class="half_rhythm"><div>Gout characteristically involves the big toe, other areas of the feet, the ankle, or the knees.</div></li><li class="half_rhythm"><div>Onset is acute with severe tenderness and redness of the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> joint.</div></li><li class="half_rhythm"><div>While not all <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals have gout, virtually all families have a number of family members who have gout.</div></li><li class="half_rhythm"><div>In those with a strong family history of ADTKD-<i>UMOD</i>, diagnosis of gout is usually made by the <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual or a parent. As renal function worsens, gout worsens and the frequency of attacks increases.</div></li><li class="half_rhythm"><div>Without treatment, tophi (large subcutaneous depositions of uric acid) and crippling arthritis can develop.</div></li><li class="half_rhythm"><div>Hyperuricemia is not a constant finding: some women older than age 16 years who have a <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> have been found to have a normal serum uric acid concentration [<a class="bk_pop" href="#mckd2.REF.bleyer.2003.867">Bleyer &#x00026; Hart 2003</a>, <a class="bk_pop" href="#mckd2.REF.dahan.2003.2883">Dahan et al 2003</a>].</div></li></ul></div><div id="mckd2.GenotypePhenotype_Correlations"><h3>Genotype-Phenotype Correlations</h3><p>The <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> <a class="figpopup" href="/books/NBK1356/table/mckd2.T.umod_pathogenic_variants_discuss/?report=objectonly" target="object" rid-figpopup="figmckd2Tumodpathogenicvariantsdiscuss" rid-ob="figobmckd2Tumodpathogenicvariantsdiscuss">p.Val93_Gly97del/insAASC</a> is associated with less frequent gout and possibly a later age of onset of ESRD [<a class="bk_pop" href="#mckd2.REF.smith.2011.2766">Smith et al 2011</a>].</p></div><div id="mckd2.Penetrance"><h3>Penetrance</h3><p>Penetrance appears to be complete, although some individuals (especially females) may not develop ESRD until the sixth or seventh decade.</p><p>The <a class="def" href="/books/n/gene/glossary/def-item/penetrance/">penetrance</a> of hyperuricemia has been estimated at 92% in people with ADTKD-<i>UMOD</i> [<a class="bk_pop" href="#mckd2.REF.bleyer.2003.36">Bleyer et al 2003</a>].</p></div><div id="mckd2.Nomenclature"><h3>Nomenclature</h3><p>According to the nomenclature from 2015 [<a class="bk_pop" href="#mckd2.REF.eckardt.2015.676">Eckardt et al 2015</a>] the term "<a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> tubulointerstitial kidney disease" (ADTKD) refers to the following disorders characterized by: (1) autosomal dominant inheritance; (2) slowly progressive chronic tubulointerstitial kidney disease resulting in ESRD in the third through seventh decade of life; (3) urinalysis revealing a bland urinary sediment (i.e., little blood or protein); and (4) renal ultrasound examination that is normal early in the disease course [<a class="bk_pop" href="#mckd2.REF.bleyer.2010.366">Bleyer et al 2010</a>]:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/mckd1/"><b>Autosomal dominant tubulointerstitial kidney disease &#x02013; <i>MUC1</i>-related</b><b> (ADTKD<i>-MUC1</i>) </b>(previously medullary cystic kidney disease type 1</a>). Autosomal dominant interstitial kidney disease that is associated with a <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in <i>MUC1</i> [<a class="bk_pop" href="#mckd2.REF.kirby.2013.299">Kirby et al 2013</a>]</div></li><li class="half_rhythm"><div><b>Autosomal dominant tubulointerstitial kidney disease &#x02013; <i>UMOD</i>-related (ADTKD-<i>UMOD</i>)</b> (previously <i>UMOD</i>-associated kidney disease). Familial juvenile hyperuricemic nephropathy type 1, medullary cystic kidney disease type 2 [MCKD2], and uromodulin storage disease</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hyper-nfj2/"><b>Autosomal dominant tubulointerstitial kidney disease &#x02013; <i>REN</i>-related</b>
<b>(ADTKD-<i>REN</i>) </b>(previously familial juvenile hyperuricemic nephropathy type 2</a>). Also known as <i>REN</i>-associated kidney disease [<a class="bk_pop" href="#mckd2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</a>]</div></li></ul><p>Note: (1) The term "nephronophthisis/medullary cystic kidney disease (NPH/MCKD) complex" was used in the past to refer to both <a class="def" href="/books/n/gene/glossary/def-item/autosomal-recessive/">autosomal recessive</a> and <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> forms of hereditary chronic tubulointerstitial disease [<a class="bk_pop" href="#mckd2.REF.hildebrandt.1992.802">Hildebrandt et al 1992</a>]. Nephronophthisis is now used to refer to a group of conditions with autosomal recessive inheritance that present in childhood with chronic kidney failure. These conditions are caused by pathogenic variants in at least 12 different genes, denoted as nephrocystins (<i>NPHP1</i> &#x02013; <i>NPHP11</i>; <i>NPHP1L</i>) [<a class="bk_pop" href="#mckd2.REF.wolf.2011.181">Wolf &#x00026; Hildebrandt 2011</a>]. Clinical characteristics include polyuria, anemia, and slowly progressive kidney failure. See <a href="/books/n/gene/nephron-ov/">Nephronophthisis</a>. (2) Medullary sponge kidney (MSK), associated with calcifications of the medulla of the kidney, hypercalciuria, hematuria, and tubular acidification defects [<a class="bk_pop" href="#mckd2.REF.gambaro.2006.663">Gambaro et al 2006</a>], is not in any way related to medullary cystic kidney disease.</p></div><div id="mckd2.Prevalence"><h3>Prevalence</h3><p>ADTKD-<i>UMOD</i> is rare, accounting for &#x0003c;1% of ESRD. However, ADTKD-<i>UMOD</i> has been chronically underdiagnosed and prevalence rates may be somewhat higher.</p></div></div><div id="mckd2.Genetically_Related_Allelic_Disord"><h2 id="_mckd2_Genetically_Related_Allelic_Disord_">Genetically Related (Allelic) Disorders</h2><p>No phenotypes other than those discussed in this <i>GeneReview</i> are known to be associated with <a class="def" href="/books/n/gene/glossary/def-item/germline/">germline</a> pathogenic variants in <i>UMOD</i>.</p></div><div id="mckd2.Differential_Diagnosis"><h2 id="_mckd2_Differential_Diagnosis_">Differential Diagnosis</h2><p>See <a class="figpopup" href="/books/NBK1356/figure/mckd2.F1/?report=objectonly" target="object" rid-figpopup="figmckd2F1" rid-ob="figobmckd2F1">Figure 1</a> for a diagnostic algorithm for inherited kidney disease.</p><div class="iconblock whole_rhythm clearfix ten_col fig" id="figmckd2F1" co-legend-rid="figlgndmckd2F1"><a href="/books/NBK1356/figure/mckd2.F1/?report=objectonly" target="object" title="Figure 1. " class="img_link icnblk_img figpopup" rid-figpopup="figmckd2F1" rid-ob="figobmckd2F1"><img class="small-thumb" src="/books/NBK1356/bin/mckd2-Image001.gif" src-large="/books/NBK1356/bin/mckd2-Image001.jpg" alt="Figure 1. " /></a><div class="icnblk_cntnt" id="figlgndmckd2F1"><h4 id="mckd2.F1"><a href="/books/NBK1356/figure/mckd2.F1/?report=objectonly" target="object" rid-ob="figobmckd2F1">Figure 1. </a></h4><p class="float-caption no_bottom_margin">Testing strategy for inherited kidney disease &#x02013; 2015 update </p></div></div><p><b>Hereditary glomerulonephritis.</b> Affected individuals usually have proteinuria and/or hematuria. If blood or protein is present in the urine, consider inherited glomerulonephritis (e.g., <a href="/books/n/gene/alport/">Alport syndrome</a>). Rarely, individuals with <i>UMOD-</i>associated kidney disease have been found to have proteinuria; however, this is uncharacteristic.</p><p><b>Polycystic kidney disease.</b> If the urinary sediment is bland (i.e., with little blood or protein) in persons with kidney disease inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner, one must exclude <a href="/books/n/gene/pkd-ad/">autosomal dominant polycystic kidney disease</a> (ADPKD), in which a large number of cysts are seen on renal ultrasound examination in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals older than age 25 years.</p><p><b>Other forms of ADTKD.</b> If the individual does not have ADPKD and the urinary sediment is bland, consider the following forms of <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> tubulointerstitial kidney disease:</p><ul><li class="half_rhythm"><div><a href="/books/n/gene/mckd1/">ADTKD-<i>MUC1</i></a> is associated with pathogenic variants in <i>MUC1</i>. Affected individuals have slowly progressive chronic kidney disease and minimal proteinuria. An important differentiating factor is that in ADTKD-<i>MUC1</i> gout usually only occurs in the setting of Stage III or later chronic kidney disease. Affected individuals do not suffer from anemia or other manifestations in childhood.</div></li><li class="half_rhythm"><div><a href="/books/n/gene/hyper-nfj2/">ADTKD-<i>REN</i></a> is associated with pathogenic variants in <i>REN</i> [<a class="bk_pop" href="#mckd2.REF.zivn_.2009.204">Zivn&#x000e1; et al 2009</a>]. Like ADTKD-<i>UMOD</i>, this condition is associated with early-onset gout and slowly progressive chronic kidney disease. Persons with a <i>REN</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> also manifest hypoproliferative anemia in childhood.</div></li></ul><p><a href="/books/n/gene/fabry/"><b>Fabry disease</b></a><b>,</b> an <a class="def" href="/books/n/gene/glossary/def-item/x-linked/">X-linked</a> disorder, results from deficient activity of the enzyme &#x003b1;-galactosidase (&#x003b1;-Gal) A and progressive lysosomal deposition of globotriaosylceramide (GL-3) in cells throughout the body. The classic form, occurring in males with &#x0003c;1% &#x003b1;-Gal A activity, usually has its onset in childhood or adolescence with periodic crises of severe pain in the extremities (acroparesthesias), the appearance of vascular cutaneous lesions (angiokeratomas), hypohidrosis, characteristic corneal and lenticular opacities, and proteinuria (which usually exceeds that seen in ADTKD-<i>UMOD</i>). Gradual deterioration of renal function to ESRD usually occurs in the third to fifth decade. Males with &#x0003e;1% &#x003b1;-Gal A activity have a cardiac or renal variant <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a>. Rarely, <a class="def" href="/books/n/gene/glossary/def-item/heterozygous/">heterozygous</a> <a class="def" href="/books/n/gene/glossary/def-item/carrier/">carrier</a> females may have symptoms as severe as those observed in males with the classic phenotype.</p></div><div id="mckd2.Management"><h2 id="_mckd2_Management_">Management</h2><div id="mckd2.Evaluations_Following_Initial_Diag"><h3>Evaluations Following Initial Diagnosis</h3><p>To establish the extent of disease and needs in an individual diagnosed with ADTKD-<i>UMOD</i>, the following evaluations are recommended:</p><ul><li class="half_rhythm"><div>Determination of kidney function (measurement of serum creatinine concentration)</div></li><li class="half_rhythm"><div>Measurement of serum uric acid concentration</div></li><li class="half_rhythm"><div>Referral to a nephrologist because of the possibility of progression to chronic kidney disease</div></li><li class="half_rhythm"><div>Consultation with a clinical geneticist and/or genetic counselor</div></li></ul></div><div id="mckd2.Treatment_of_Manifestations"><h3>Treatment of Manifestations</h3><p><b>Hyperuricemia/gout</b></p><ul><li class="half_rhythm"><div>Acute gout typically responds well to prednisone, short-term nonsteroidal anti-inflammatory drugs (NSAIDs), or colchicine.</div></li><li class="half_rhythm"><div>Gout prevention with allopurinol or probenecid should be considered.</div><ul><li class="half_rhythm"><div>With allopurinol treatment, serum uric acid concentration returns to normal and gout attacks can be entirely prevented.</div></li><li class="half_rhythm"><div>Lifelong therapy with allopurinol may be required.</div></li><li class="half_rhythm"><div>In individuals with allergies or intolerance to allopurinol, febuxostat may be considered; however, no data on the use of this medication in <i>UMOD</i>-associated kidney disease are available at present.</div></li></ul></li></ul><p><b>Kidney disease.</b> Referral to a nephrologist is indicated to monitor kidney function, evaluate for manifestations of chronic kidney disease, and prepare for renal replacement therapy when renal insufficiency occurs.</p><ul><li class="half_rhythm"><div>Renal replacement therapies such as hemodialysis and peritoneal dialysis replace renal function but are associated with potential complications.</div></li><li class="half_rhythm"><div>Kidney transplantation cures ADTKD-<i>UMOD</i>. The transplanted kidney does not develop the disease.</div></li><li class="half_rhythm"><div>Allopurinol may slow the progression of kidney disease, although reliable data are not available [<a class="bk_pop" href="#mckd2.REF.pirson.2000.357">Pirson et al 2000</a>, <a class="bk_pop" href="#mckd2.REF.fairbanks.2002.597">Fairbanks et al 2002</a>].</div></li></ul></div><div id="mckd2.Prevention_of_Primary_Manifestatio"><h3>Prevention of Primary Manifestations</h3><p>Treatment of hyperuricemia with allopurinol, probenecid, or febuxostat can prevent development of gout.</p><p>Kidney transplantation cures ADTKD-<i>UMOD</i>. The transplanted kidney does not develop the disease.</p></div><div id="mckd2.Surveillance"><h3>Surveillance</h3><p>Appropriate surveillance includes the following:</p><ul><li class="half_rhythm"><div>Measurement of serum creatinine concentration at least annually in <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals, and more frequently in those with severe disease</div></li><li class="half_rhythm"><div>Measurement of serum uric acid concentration at least annually</div></li></ul></div><div id="mckd2.AgentsCircumstances_to_Avoid"><h3>Agents/Circumstances to Avoid</h3><p>Volume depletion and dehydration may worsen hyperuricemia and lead to more frequent attacks of gout.</p><p>High meat and seafood intake could exacerbate gout.</p><p>Drugs known to be nephrotoxic should be avoided. NSAIDs are appropriate for short-term administration for treatment of gout or similar painful conditions. However, patients should avoid chronic daily use.</p></div><div id="mckd2.Evaluation_of_Relatives_at_Risk"><h3>Evaluation of Relatives at Risk</h3><p>It is appropriate to evaluate apparently asymptomatic relatives of an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individual by <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in order to identify as early as possible those who would benefit from initiation of treatment and preventive measures. Particularly important are:</p><ul><li class="half_rhythm"><div>Adolescents because of their increased risk for gout, which can be prevented with allopurinol treatment;</div></li><li class="half_rhythm"><div>Relatives interested in donating a kidney to an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member.</div></li></ul><p>See <a href="#mckd2.Related_Genetic_Counseling_Issues">Genetic Counseling</a> for issues related to testing of at-risk relatives for <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> purposes.</p></div><div id="mckd2.Pregnancy_Management"><h3>Pregnancy Management</h3><p>No pregnancy issues are particular to ADTKD-<i>UMOD</i>. However, in general, chronic kidney disease, depending on the stage, can affect pregnancy through increased hypertension and increased fetal loss.</p><p>Women of childbearing age who are taking medications such as allopurinol or an angiotensin-converting enzyme (ACE) inhibitor should discuss their medication regimen with their physician prior to conception.</p><ul><li class="half_rhythm"><div>A recent study has suggested that allopurinol use during pregnancy may be associated with fetal malformations. While the study included women who were on many other medications when they became pregnant, allopurinol should be discontinued in women who are pregnant or who may become pregnant [<a class="bk_pop" href="#mckd2.REF.hoeltzenbein.2013.e66637">Hoeltzenbein et al 2013</a>].</div></li><li class="half_rhythm"><div>Similarly, the use of ACE inhibitors during the second and third trimesters of pregnancy can result in fetal damage and death. Women who are taking ACE inhibitors prior to pregnancy or at the time of conception should be transitioned to another antihypertensive medication.</div></li></ul><p>Ideally, women should not take either allopurinol or an ACE inhibitor during pregnancy.</p></div><div id="mckd2.Therapies_Under_Investigation"><h3>Therapies Under Investigation</h3><p>Search <a href="http://clinicaltrials.gov/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">ClinicalTrials.gov</a> in the US and <a href="http://www.clinicaltrialsregister.eu/ctr-search/search" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">EU Clinical Trials Register</a> in Europe for access to information on clinical studies for a wide range of diseases and conditions. Note: There may not be clinical trials for this disorder.</p></div></div><div id="mckd2.Genetic_Counseling"><h2 id="_mckd2_Genetic_Counseling_">Genetic Counseling</h2><p>
<i>Genetic counseling is the process of providing individuals and families with
information on the nature, inheritance, and implications of genetic disorders to help them
make informed medical and personal decisions. The following section deals with genetic
risk assessment and the use of family history and genetic testing to clarify genetic
status for family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with a genetics
professional</i>. &#x02014;ED.</p><div id="mckd2.Mode_of_Inheritance"><h3>Mode of Inheritance</h3><p>Autosomal dominant tubulointerstitial kidney disease, <i>UMOD</i>-related (ADTKD-<i>UMOD</i>) is inherited in an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> manner.</p></div><div id="mckd2.Risk_to_Family_Members"><h3>Risk to Family Members</h3><p><b>Parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>Most individuals diagnosed with ADTKD-<i>UMOD</i> have an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> parent.</div></li><li class="half_rhythm"><div>A <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with ADTKD-<i>UMOD</i> may have the disorder as the result of a <i>de novo UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</div></li><li class="half_rhythm"><div>Recommendations for the evaluation of parents of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> include <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> and measurement of serum concentrations of uric acid and creatinine.</div></li><li class="half_rhythm"><div>If the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> found in the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> cannot be detected in leukocyte DNA of either parent, possible explanations include a <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> pathogenic variant in the proband or <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> in a parent. (Although no instances of germline mosaicism have been reported, it remains a possibility.)</div></li><li class="half_rhythm"><div>An apparently negative family history cannot be confirmed without <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> for the <a class="def" href="/books/n/gene/glossary/def-item/familial/">familial</a> <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>. Evaluation of parents may determine that one is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome, a milder phenotypic presentation, early death of the parent before the onset of symptoms, and/or late onset of the disease in the affected parent.</div></li></ul><p><b>Sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a></b></p><ul><li class="half_rhythm"><div>The risk to the sibs of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> depends on the genetic status of the proband's parents: if a parent of the proband is <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> and/or has a <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, the risk to the sibs of inheriting the variant is 50%.</div></li><li class="half_rhythm"><div>When the parents are clinically unaffected, the risk to the sibs of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> appears to be low.</div></li><li class="half_rhythm"><div>Parental <a class="def" href="/books/n/gene/glossary/def-item/germline-mosaicism/">germline mosaicism</a> has not been reported.</div></li></ul><p><b>Offspring of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>.</b> Each child of an individual with ADTKD-<i>UMOD</i> has a 50% chance of inheriting the <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</p><p><b>Other family members.</b> The risk to other family members depends on the status of the <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a>'s parents: if a parent has the <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, his or her family members may be at risk.</p></div><div id="mckd2.Related_Genetic_Counseling_Issues"><h3>Related Genetic Counseling Issues</h3><p>See Management, <a href="#mckd2.Evaluation_of_Relatives_at_Risk">Evaluation of Relatives at Risk</a> for information on evaluating at-risk relatives for the purpose of early diagnosis and treatment.</p><p><b>Considerations in families with an apparent <a class="def" href="/books/n/gene/glossary/def-item/de-novo/"><i>de novo</i></a> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>.</b> When neither parent of a <a class="def" href="/books/n/gene/glossary/def-item/proband/">proband</a> with an <a class="def" href="/books/n/gene/glossary/def-item/autosomal-dominant/">autosomal dominant</a> condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the pathogenic variant is <i>de novo</i>. However, non-medical explanations including <a class="def" href="/books/n/gene/glossary/def-item/alternate-paternity/">alternate paternity</a> or maternity (e.g., with assisted reproduction) and undisclosed adoption could also be explored.</p><p><b>Family planning</b></p><ul><li class="half_rhythm"><div>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy.</div></li><li class="half_rhythm"><div>It is appropriate to offer <a class="def" href="/books/n/gene/glossary/def-item/genetic-counseling/">genetic counseling</a> (including discussion of potential risks to offspring and reproductive options) to young adults who are <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> or at risk.</div></li></ul><p><b>Molecular genetic testing of at-risk asymptomatic relatives</b> of individuals with ADTKD-<i>UMOD</i> is possible after <a class="def" href="/books/n/gene/glossary/def-item/molecular-genetic-testing/">molecular genetic testing</a> has identified the specific <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> in the family. Such testing is helpful in predicting the future development of chronic kidney disease and should be performed if the family member is considering becoming a kidney donor.</p><p><b>Testing of at-risk asymptomatic individuals younger than age 18 years.</b> Because of the increased risk for gout, which can be prevented with allopurinol treatment in adolescents who have a <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a>, testing of at-risk family members during adolescence may be appropriate.</p><p><b>Symptomatic individuals younger than age 18 years</b> usually benefit from having a specific diagnosis established.</p><p><b>DNA banking</b> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> individuals.</p></div><div id="mckd2.Prenatal_Testing_and_Preimplantati"><h3>Prenatal Testing and Preimplantation Genetic Diagnosis</h3><p>Once the <i>UMOD</i> <a class="def" href="/books/n/gene/glossary/def-item/pathogenic-variant/">pathogenic variant</a> has been identified in an <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> family member, prenatal testing for a pregnancy at increased risk and <a class="def" href="/books/n/gene/glossary/def-item/preimplantation-genetic-diagnosis/">preimplantation genetic diagnosis</a> for ADTKD-<i>UMOD</i> are possible.</p><p>Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. While most centers would consider decisions regarding prenatal testing to be the choice of the parents, discussion of these issues is appropriate.</p><p>Individuals who have ADTKD-<i>UMOD</i> will not be <a class="def" href="/books/n/gene/glossary/def-item/affected/">affected</a> with kidney disease for 30 to 40 years. It is anticipated that rapid advances in treatment, renal replacement therapy, and transplantation will result in marked improvements in care for individuals with this disease.</p></div></div><div id="mckd2.Resources"><h2 id="_mckd2_Resources_">Resources</h2><p>
<i>GeneReviews staff has selected the following disease-specific and/or umbrella
support organizations and/or registries for the benefit of individuals with this disorder
and their families. GeneReviews is not responsible for the information provided by other
organizations. For information on selection criteria, click <a href="/books/n/gene/app4/">here</a>.</i></p><ul><li class="half_rhythm"><div><b>UKD Foundation, Inc.</b></div><div>Uromodulin Kidney Disease Research and Support</div><div>425 Madison Avenue</div><div>9th Floor</div><div>New York NY 10017</div><div><b>Phone:</b> 828-738-5301</div><div><a href="http://www.ukdcure.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">www.ukdcure.org</a></div></li><li class="half_rhythm"><div><b>Medline Plus</b></div><div><a href="http://www.nlm.nih.gov/medlineplus/ency/article/000465.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Medullary cystic kidney disease</a></div></li><li class="half_rhythm"><div><b>UMOD-Related Kidney Disease Registry</b></div><div><i>Wake Forest University School of Medicine is keeping a registry of families with UMOD pathogenic variants. A pamphlet about ADTKD-UMOD for patients is available as well. Please contact ableyer@wfubmc.edu if interested in participating.</i></div><div><b>Email:</b> ableyer@wakehealth.edu</div></li></ul></div><div id="mckd2.Molecular_Genetics"><h2 id="_mckd2_Molecular_Genetics_">Molecular Genetics</h2><p><i>Information in the Molecular Genetics and OMIM tables may differ from that elsewhere in the GeneReview: tables may contain more recent information. &#x02014;</i>ED.</p><div id="mckd2.molgen.TA" class="table"><h3><span class="label">Table A.</span></h3><div class="caption"><p>Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related: Genes and Databases</p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1356/table/mckd2.molgen.TA/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mckd2.molgen.TA_lrgtbl__"><table class="no_bottom_margin"><tbody><tr><th id="hd_b_mckd2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;">Gene</th><th id="hd_b_mckd2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;">Chromosome Locus</th><th id="hd_b_mckd2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;">Protein</th><th id="hd_b_mckd2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;">Locus-Specific Databases</th><th id="hd_b_mckd2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;">HGMD</th><th id="hd_b_mckd2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;">ClinVar</th></tr><tr><td headers="hd_b_mckd2.molgen.TA_1_1_1_1" rowspan="1" colspan="1" style="vertical-align:top;"><a href="/gene/7369" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=gene"><i>UMOD</i></a></td><td headers="hd_b_mckd2.molgen.TA_1_1_1_2" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/genome/gdv/?context=gene&#x00026;acc=7369" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">16p12<wbr style="display:inline-block"></wbr>​.3</a></td><td headers="hd_b_mckd2.molgen.TA_1_1_1_3" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.uniprot.org/uniprot/P07911" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Uromodulin</a></td><td headers="hd_b_mckd2.molgen.TA_1_1_1_4" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://databases.lovd.nl/shared/genes/UMOD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UMOD database</a></td><td headers="hd_b_mckd2.molgen.TA_1_1_1_5" rowspan="1" colspan="1" style="vertical-align:top;"><a href="http://www.hgmd.cf.ac.uk/ac/gene.php?gene=UMOD" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UMOD</a></td><td headers="hd_b_mckd2.molgen.TA_1_1_1_6" rowspan="1" colspan="1" style="vertical-align:top;"><a href="https://www.ncbi.nlm.nih.gov/clinvar/?term=UMOD[gene]" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UMOD</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div id="mckd2.TFA.1"><p class="no_margin">Data are compiled from the following standard references: <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> from
<a href="http://www.genenames.org/index.html" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">HGNC</a>;
<a class="def" href="/books/n/gene/glossary/def-item/chromosome/">chromosome</a> <a class="def" href="/books/n/gene/glossary/def-item/locus/">locus</a> from
<a href="http://www.omim.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">OMIM</a>;
protein from <a href="http://www.uniprot.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">UniProt</a>.
For a description of databases (Locus Specific, HGMD, ClinVar) to which links are provided, click
<a href="/books/n/gene/app1/">here</a>.</p></div></dd></dl></div></div></div><div id="mckd2.molgen.TB" class="table"><h3><span class="label">Table B.</span></h3><div class="caption"><p>OMIM Entries for Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related (<a href="/omim/162000,191845,603860,609886" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">View All in OMIM</a>) </p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1356/table/mckd2.molgen.TB/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mckd2.molgen.TB_lrgtbl__"><table><tbody><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/162000" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">162000</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">HYPERURICEMIC NEPHROPATHY, FAMILIAL JUVENILE, 1; HNFJ1</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/191845" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">191845</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">UROMODULIN; UMOD</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/603860" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">603860</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">MEDULLARY CYSTIC KIDNEY DISEASE 2; MCKD2</td></tr><tr><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">
<a href="/omim/609886" ref="pagearea=body&amp;targetsite=entrez&amp;targetcat=term&amp;targettype=omim">609886</a></td><td rowspan="1" colspan="1" style="text-align:left;vertical-align:top;">GLOMERULOCYSTIC KIDNEY DISEASE WITH HYPERURICEMIA AND ISOSTHENURIA</td></tr></tbody></table></div></div><div id="mckd2.Molecular_Pathogenesis"><h3>Molecular Pathogenesis</h3><p>Autosomal dominant tubulointerstitial kidney disease, <i>UMOD</i>-related (ADTKD-<i>UMOD</i>) is an endoplasmic reticulum storage disease resulting in chronic renal failure from deposition of abnormal uromodulin over time [<a class="bk_pop" href="#mckd2.REF.rampoldi.2003.3369">Rampoldi et al 2003</a>, <a class="bk_pop" href="#mckd2.REF.bleyer.2004.974">Bleyer et al 2004</a>].</p><p><b>Gene structure.</b> The <a class="def" href="/books/n/gene/glossary/def-item/gene/">gene</a> comprises 11 exons. Exon 1 is noncoding. Note: Exon numbering may vary in the literature; this <i>GeneReview</i> uses that of <a class="bk_pop" href="#mckd2.REF.williams.2009.2963">Williams et al [2009]</a>. See <a href="/books/NBK1356/#mckd2.molgen.TA">Table A</a> for a detailed summary of gene and protein information.</p><p><b>Pathogenic variants.</b> More than 40 pathogenic variants have been found in families with ADTKD-<i>UMOD</i> [<a class="bk_pop" href="#mckd2.REF.hart.2002.882">Hart et al 2002</a>, <a class="bk_pop" href="#mckd2.REF.dahan.2003.2883">Dahan et al 2003</a>, <a class="bk_pop" href="#mckd2.REF.rampoldi.2003.3369">Rampoldi et al 2003</a>, <a class="bk_pop" href="#mckd2.REF.turner.2003.1398">Turner et al 2003</a>, <a class="bk_pop" href="#mckd2.REF.wolf.2003.1580">Wolf et al 2003</a>, <a class="bk_pop" href="#mckd2.REF.kudo.2004.1589">Kudo et al 2004</a>, <a class="bk_pop" href="#mckd2.REF.lens.2005.52">Lens et al 2005</a>, <a class="bk_pop" href="#mckd2.REF.puig.2006.1295">Puig et al 2006</a>]. Pathogenic variants are almost exclusively <a class="def" href="/books/n/gene/glossary/def-item/missense/">missense</a> variants.</p><p>The majority of the pathogenic variants causing ADTKD-<i>UMOD</i> involve an addition or <a class="def" href="/books/n/gene/glossary/def-item/deletion/">deletion</a> of a cysteine residue or highly conserved polar residue that is likely to alter either disulfide bond formation, thereby disrupting the correct protein folding [<a class="bk_pop" href="#mckd2.REF.whiteman.2003.727">Whiteman &#x00026; Handford 2003</a>], or hydrophobicity distribution responsible for protein spatial flexibility [<a class="bk_pop" href="#mckd2.REF.xu.1997.68">Xu et al 1997</a>].</p><p>Pathogenic variants have been identified in exons 3, 4, 5, and 7 of <i>UMOD</i>.</p><div id="mckd2.T.umod_pathogenic_variants_discuss" class="table"><h3><span class="label">Table 4. </span></h3><div class="caption"><p><i>UMOD</i> Pathogenic Variants Discussed in This <i>GeneReview</i></p></div><p class="large-table-link" style="display:none"><span class="right"><a href="/books/NBK1356/table/mckd2.T.umod_pathogenic_variants_discuss/?report=objectonly" target="object">View in own window</a></span></p><div class="large_tbl" id="__mckd2.T.umod_pathogenic_variants_discuss_lrgtbl__"><table class="no_bottom_margin"><thead><tr><th id="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_1" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">DNA Nucleotide Change</th><th id="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_2" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Predicted Protein Change</th><th id="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_3" scope="col" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">Reference Sequences</th></tr></thead><tbody><tr><td headers="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_1" scope="row" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">c.278_289delTCTGCCCCGAAGinsCCGCCTCCT</td><td headers="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_2" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;">p.Val93_Gly97delinsAlaAlaSerCys</td><td headers="hd_h_mckd2.T.umod_pathogenic_variants_discuss_1_1_1_3" rowspan="1" colspan="1" style="text-align:left;vertical-align:middle;"><a href="/nuccore/NM_003361.3" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NM_003361<wbr style="display:inline-block"></wbr>​.3</a><br /><a href="/protein/NP_003352.2" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_003352<wbr style="display:inline-block"></wbr>​.2</a></td></tr></tbody></table></div><div><div><dl class="temp-labeled-list small"><dt></dt><dd><div><p class="no_margin">Note on variant classification: Variants listed in the table have been provided by the authors. <i>GeneReviews</i> staff have not independently verified the classification of variants.</p></div></dd><dt></dt><dd><div><p class="no_margin">Note on nomenclature: <i>GeneReviews</i> follows the standard naming conventions of the Human Genome Variation Society (<a href="http://varnomen.hgvs.org/" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">varnomen<wbr style="display:inline-block"></wbr>​.hgvs.org</a>). See <a href="/books/n/gene/app3/">Quick Reference</a> for an explanation of nomenclature.</p></div></dd></dl></div></div></div><p><b>Normal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Uromodulin is a large glycoprotein with a large number of cysteine residues [<a class="bk_pop" href="#mckd2.REF.serafinicessi.2003.658">Serafini-Cessi et al 2003</a>] (reference sequence <a href="/protein/NP_001008390.1" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">NP_001008390.1</a>). Uromodulin is produced only in the thick ascending limb of Henle's loop of the renal tubule; therefore, disease is limited to the kidney. While uromodulin is the most common protein found in normal human urine, its function is uncertain. Uromodulin is likely responsible for maintaining the integrity of the thick ascending limb of Henle's loop, the kidney region in which the water permeability is remarkably low and salts are efficiently absorbed. Although it has been postulated that uromodulin is important in preventing urinary tract infections, individuals with abnormal uromodulin do not have an increased incidence of urinary tract infections or kidney stones.</p><p><b>Abnormal <a class="def" href="/books/n/gene/glossary/def-item/gene-product/">gene product</a>.</b> Increasing evidence suggests that intracellular accumulation of abnormal uromodulin leads to increased apoptosis and is likely an important contributor to the pathogenesis of this disorder [<a class="bk_pop" href="#mckd2.REF.williams.2009.2963">Williams et al 2009</a>]. Abnormal uromodulin may also prevent the proper function of ion channels in the thick ascending limb, resulting in mild natriuresis leading to proximal tubular reabsorption of urate and hyperuricemia [<a class="bk_pop" href="#mckd2.REF.renigunta.2011.2224">Renigunta et al 2011</a>].</p><p>Histochemical studies have shown abnormal uromodulin deposition in the endoplasmic reticulum of cells of the thick ascending limb of Henle's loop. In heterozygotes, urinary excretion of uromodulin is much less than half the expected amount, likely resulting from a <a class="def" href="/books/n/gene/glossary/def-item/dominant-negative/">dominant-negative</a> effect (e.g., interference with synthesis of the normal uromodulin by abnormal uromodulin). Accordingly, the abnormal expression of the mutated uromodulin in the thick ascending limb of Henle's loop of the renal tubule decreases NaCl reabsorption and subsequently induces a state of volume contraction known to promote the proximal reabsorption of urate [<a class="bk_pop" href="#mckd2.REF.renigunta.2011.2224">Renigunta et al 2011</a>].</p></div></div><div id="mckd2.References"><h2 id="_mckd2_References_">References</h2><div id="mckd2.Published_Guidelines__Consensus_St"><h3>Published Guidelines / Consensus Statements</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF1">Committee on Bioethics, Committee on Genetics, and American College of Medical Genetics and Genomics Social, Ethical, Legal Issues Committee. Ethical and policy issues in genetic testing and screening of children. Available <a href="http://pediatrics.aappublications.org/content/131/3/620.full.pdf" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2013. Accessed 2-21-19. [<a href="/pubmed/23428972" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23428972</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF2">National Society of Genetic Counselors. Position statement on genetic testing of minors for adult-onset conditions. Available <a href="http://www.nsgc.org/p/bl/et/blogaid=860" ref="pagearea=cite-ref&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">online</a>. 2018. Accessed 2-21-19.</div></li></ul></div><div id="mckd2.Literature_Cited"><h3>Literature Cited</h3><ul class="simple-list"><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.bleyer.2010.366">Bleyer AJ, Hart PS, Kmoch S. Hereditary interstitial kidney disease. <span><span class="ref-journal">Semin Nephrol. </span>2010;<span class="ref-vol">30</span>:366–73.</span> [<a href="/pmc/articles/PMC4264385/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4264385</span></a>] [<a href="/pubmed/20807609" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20807609</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.bleyer.2003.867">Bleyer AJ, Hart TC. Familial juvenile hyperuricaemic nephropathy. <span><span class="ref-journal">QJM. </span>2003;<span class="ref-vol">96</span>:867–8.</span> [<a href="/pubmed/14566042" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14566042</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.bleyer.2004.974">Bleyer AJ, Hart TC, Shihabi Z, Robins V, Hoyer JR. Mutations in the uromodulin gene decrease urinary excretion of Tamm-Horsfall protein. <span><span class="ref-journal">Kidney Int. </span>2004;<span class="ref-vol">66</span>:974–7.</span> [<a href="/pubmed/15327389" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15327389</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.bleyer.2005.824">Bleyer AJ, Hart TC, Willingham MC, Iskandar SS, Gorry MC, Trachtman H. Clinico-pathologic findings in medullary cystic kidney disease type 2. <span><span class="ref-journal">Pediatr Nephrol. </span>2005;<span class="ref-vol">20</span>:824–7.</span> [<a href="/pubmed/15844001" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15844001</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.bleyer.2003.36">Bleyer AJ, Woodard AS, Shihabi Z, Sandhu J, Zhu H, Satko SG, Weller N, Deterding E, McBride D, Gorry MC, Xu L, Ganier D, Hart TC. Clinical characterization of a family with a mutation in the uromodulin (Tamm-Horsfall glycoprotein) gene. <span><span class="ref-journal">Kidney Int. </span>2003;<span class="ref-vol">64</span>:36–42.</span> [<a href="/pubmed/12787393" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12787393</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.cameron.1993.105">Cameron JS, Moro F, Simmonds HA. Gout, uric acid and purine metabolism in paediatric nephrology. <span><span class="ref-journal">Pediatr Nephrol. </span>1993;<span class="ref-vol">7</span>:105–18.</span> [<a href="/pubmed/8439471" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8439471</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.dahan.2003.2883">Dahan K, Devuyst O, Smaers M, Vertommen D, Loute G, Poux JM, Viron B, Jacquot C, Gagnadoux MF, Chauveau D, Buchler M, Cochat P, Cosyns JP, Mougenot B, Rider MH, Antignac C, Verellen-Dumoulin C, Pirson Y. A cluster of mutations in the UMOD gene causes familial juvenile hyperuricemic nephropathy with abnormal expression of uromodulin. <span><span class="ref-journal">J Am Soc Nephrol. </span>2003;<span class="ref-vol">14</span>:2883–93.</span> [<a href="/pubmed/14569098" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14569098</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.dahan.2001.2348">Dahan K, Fuchshuber A, Adamis S, Smaers M, Kroiss S, Loute G, Cosyns JP, Hildebrandt F, Verellen-Dumoulin C, Pirson Y. Familial juvenile hyperuricemic nephropathy and autosomal dominant medullary cystic kidney disease type 2: two facets of the same disease? <span><span class="ref-journal">J Am Soc Nephrol. </span>2001;<span class="ref-vol">12</span>:2348–57.</span> [<a href="/pubmed/11675411" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11675411</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.eckardt.2015.676">Eckardt K-U, Alper SL, Antignac C, Bleyer AJ, Chauveau D, Dahan K, Deltas C, Hosking A, Kmoch S, Rampoldi L, Wiesener M, Wolf MT, Devuyst O. Autosomal dominant tubulointerstitial kidney disease: Diagnosis, classification, and management- a KDIGO consensus report. <span><span class="ref-journal">Kidney Int. </span>2015;<span class="ref-vol">88</span>:676–683.</span> [<a href="/pubmed/25738250" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 25738250</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.fairbanks.2002.597">Fairbanks LD, Cameron JS, Venkat-Raman G, Rigden SP, Rees L. Van'T Hoff W, Mansell M, Pattison J, Goldsmith DJ, Simmonds HA. Early treatment with allopurinol in familial juvenile hyerpuricaemic nephropathy (FJHN) ameliorates the long-term progression of renal disease. <span><span class="ref-journal">QJM. </span>2002;<span class="ref-vol">95</span>:597–607.</span> [<a href="/pubmed/12205338" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12205338</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.gagnadoux.1989.50">Gagnadoux MF, Bacri JL, Broyer M, Habib R. Infantile chronic tubulo-interstitial nephritis with cortical microcysts: variant of nephronophthisis or new disease entity? <span><span class="ref-journal">Pediatr Nephrol. </span>1989;<span class="ref-vol">3</span>:50–5.</span> [<a href="/pubmed/2702088" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 2702088</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.gambaro.2006.663">Gambaro G, Feltrin GP, Lupo A, Bonfante L, D'Angelo A, Antonello A. Medullary sponge kidney (Lenarduzzi-Cacchi-Ricci disease): a Padua Medical School discovery in the 1930s. <span><span class="ref-journal">Kidney Int. </span>2006;<span class="ref-vol">69</span>:663–70.</span> [<a href="/pubmed/16395272" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 16395272</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.harkness.1969.773">Harkness RA, Nicol AD. Plasma uric acid levels in children. <span><span class="ref-journal">Arch Dis Child. </span>1969;<span class="ref-vol">44</span>:773–8.</span> [<a href="/pmc/articles/PMC2020338/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2020338</span></a>] [<a href="/pubmed/5356987" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 5356987</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.hart.2002.882">Hart TC, Gorry MC, Hart PS, Woodard AS, Shihabi Z, Sandhu J, Shirts B, Xu L, Zhu H, Barmada MM, Bleyer AJ. Mutations of the UMOD gene are responsible for medullary cystic kidney disease 2 and familial juvenile hyperuricaemic nephropathy. <span><span class="ref-journal">J Med Genet. </span>2002;<span class="ref-vol">39</span>:882–92.</span> [<a href="/pmc/articles/PMC1757206/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC1757206</span></a>] [<a href="/pubmed/12471200" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12471200</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.hildebrandt.1992.802">Hildebrandt F, Waldherr R, Kutt R, Brandis M. The nephronophthisis complex: clinical and genetic aspects. <span><span class="ref-journal">Clin Investig. </span>1992;<span class="ref-vol">70</span>:802–8.</span> [<a href="/pubmed/1450635" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1450635</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.hoeltzenbein.2013.e66637">Hoeltzenbein M, Stieler K, Panse M, Wacker E, Schaefer C. Allopurinol use during pregnancy: Outcome of 31 prospectively ascertained cases and a phenotype possibly indicative for teratogenicity. <span><span class="ref-journal">PLoS One. </span>2013;<span class="ref-vol">8</span>:e66637.</span> [<a href="/pmc/articles/PMC3686712/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3686712</span></a>] [<a href="/pubmed/23840514" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23840514</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.kirby.2013.299">Kirby A, Gnirke A, Jaffe DB, Bare&#x00161;ov&#x000e1; V, Pochet N, Blumenstiel B, Ye C, Aird D, Stevens C, Robinson JT, Cabili MN, Gat-Viks I, Kelliher E, Daza R, DeFelice M, H&#x0016f;lkov&#x000e1; H, Sovov&#x000e1; J, Vylet'al P, Antignac C, Guttman M, Handsaker RE, Perrin D, Steelman S, Sigurdsson S, Scheinman SJ, Sougnez C, Cibulskis K, Parkin M, Green T, Rossin E, Zody MC, Xavier RJ, Pollak MR, Alper SL, Lindblad-Toh K, Gabriel S, Hart PS, Regev A, Nusbaum C, Kmoch S, Bleyer AJ, Lander ES, Daly MJ. Mutations causing medullary cystic kidney disease type 1 lie in a large VNTR in MUC1 missed by massively parallel sequencing. <span><span class="ref-journal">Nat Genet. </span>2013;<span class="ref-vol">45</span>:299–303.</span> [<a href="/pmc/articles/PMC3901305/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3901305</span></a>] [<a href="/pubmed/23396133" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 23396133</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.kudo.2004.1589">Kudo E, Kamatani N, Tezuka O, Taniguchi A, Yamanaka H, Yabe S, Osabe D, Shinohara S, Nomura K, Segawa M, Miyamoto T, Moritani M, Kunika K, Itakura M. Familial juvenile hyperuricemic nephropathy: detection of mutations in the uromodulin gene in five Japanese families. <span><span class="ref-journal">Kidney Int. </span>2004;<span class="ref-vol">65</span>:1589–97.</span> [<a href="/pubmed/15086896" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15086896</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.lens.2005.52">Lens XM, Banet JF, Outeda P, Barrio-Lucia V. A novel pattern of mutation in uromodulin disorders: autosomal dominant medullary cystic kidney disease type 2, familial juvenile hyperuricemic nephropathy, and autosomal dominant glomerulocystic kidney disease. <span><span class="ref-journal">Am J Kidney Dis. </span>2005;<span class="ref-vol">46</span>:52–7.</span> [<a href="/pubmed/15983957" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 15983957</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.mcbride.1998.357">McBride MB, Rigden S, Haycock GB, Dalton N, Van't Hoff W, Rees L, Raman GV, Moro F, Ogg CS, Cameron JS, Simmonds HA. Presymptomatic detection of familial juvenile hyperuricaemic nephropathy in children. <span><span class="ref-journal">Pediatr Nephrol. </span>1998;<span class="ref-vol">12</span>:357–64.</span> [<a href="/pubmed/9686952" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 9686952</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.mikkelsen.1965.242">Mikkelsen WM, Dodge HJ, Valkenburg H. the distribution of serum uric acid values in a population unselected as to gout or hyperuricemia: Tecumseh, Michigan 1959-1960. <span><span class="ref-journal">Am J Med. </span>1965;<span class="ref-vol">39</span>:242–51.</span> [<a href="/pubmed/14320691" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14320691</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.moro.1991.263">Moro F, Ogg CS, Simmonds HA, Cameron JS, Chantler C, McBride MB, Duley JA, Davies PM. Familial juvenile gouty nephropathy with renal urate hypoexcretion preceding renal disease. <span><span class="ref-journal">Clin Nephrol. </span>1991;<span class="ref-vol">35</span>:263–9.</span> [<a href="/pubmed/1873940" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 1873940</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.pirson.2000.357">Pirson Y, Loute G, Cosyns JP, Dahan K, Verellen C. Autosomal-dominant chronic interstitial nephritis with early hyperuricemia. <span><span class="ref-journal">Adv Nephrol Necker Hosp. </span>2000;<span class="ref-vol">30</span>:357–69.</span> [<a href="/pubmed/11068651" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 11068651</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.puig.1993.357">Puig JG, Miranda ME, Mateos FA, Picazo ML, Jimenez ML, Calvin TS, Gil AA. Hereditary nephropathy associated with hyperuricemia and gout. <span><span class="ref-journal">Arch Intern Med. </span>1993;<span class="ref-vol">153</span>:357–65.</span> [<a href="/pubmed/8427538" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8427538</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.puig.2006.1295">Puig JG, Prior C, Martinez-Ara J, Torres RJ. Familial nephropathy associated with hyperuricemia in spain: our experience with 3 families harbouring a UMOD mutation. <span><span class="ref-journal">Nucleosides Nucleotides Nucleic Acids. </span>2006;<span class="ref-vol">25</span>:1295–300.</span> [<a href="/pubmed/17065110" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17065110</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.rampoldi.2003.3369">Rampoldi L, Caridi G, Santon D, Boaretto F, Bernascone I, Lamorte G, Tardanico R, Dagnino M, Colussi G, Scolari F, Ghiggeri GM, Amoroso A, Casari G. Allelism of MCKD, FJHN and GCKD caused by impairment of uromodulin export dynamics. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:3369–84.</span> [<a href="/pubmed/14570709" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14570709</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.renigunta.2011.2224">Renigunta A, Renigunta V, Saritas T, Decher N, Mutig K, Waldegger S. Tamm-Horsfall glycoprotein interacts with renal outer medullary potassium channel ROMK2 and regulates its function. <span><span class="ref-journal">J Biol Chem. </span>2011;<span class="ref-vol">286</span>:2224–35.</span> [<a href="/pmc/articles/PMC3023518/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3023518</span></a>] [<a href="/pubmed/21081491" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 21081491</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.richmond.1981.163">Richmond JM, Kincaid-Smith P, Whitworth JA, Becker GJ. Familial urate nephropathy. <span><span class="ref-journal">Clin Nephrol. </span>1981;<span class="ref-vol">16</span>:163–8.</span> [<a href="/pubmed/7296976" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7296976</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.sch_ffer.2010.1355">Sch&#x000e4;ffer P, Gombos E, Meichelbeck K, Kiss A, Hart PS, Bleyer AJ. Childhood course of renal insufficiency in a family with a uromodulin gene mutation. <span><span class="ref-journal">Pediatr Nephrol. </span>2010;2010;<span class="ref-vol">25</span>:1355–60.</span> [<a href="/pmc/articles/PMC4264542/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4264542</span></a>] [<a href="/pubmed/20151160" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20151160</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.serafinicessi.2003.658">Serafini-Cessi F, Malagolini N, Cavallone D. Tamm-Horsfall glycoprotein: biology and clinical relevance. <span><span class="ref-journal">Am J Kidney Dis. </span>2003;<span class="ref-vol">42</span>:658–76.</span> [<a href="/pubmed/14520616" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14520616</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.simmonds.1980.176">Simmonds HA, Warren DJ, Cameron JS, Potter CF, Farebrother DA. Familial gout and renal failure in young women. <span><span class="ref-journal">Clin Nephrol. </span>1980;<span class="ref-vol">14</span>:176–82.</span> [<a href="/pubmed/7428192" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 7428192</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.smith.2011.2766">Smith GD, Robinson C, Stewart AP, Edwards EL, Karet HI, Norden AG, Sandford RN, Karet Frankl FE. Characterization of a recurrent in-frame UMOD indel mutation causing late-onset autosomal dominant end-stage renal failure. <span><span class="ref-journal">Clin J Am Soc Nephrol. </span>2011;<span class="ref-vol">6</span>:2766–74.</span> [<a href="/pmc/articles/PMC3255364/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC3255364</span></a>] [<a href="/pubmed/22034507" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 22034507</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.stib_rkov_.2006.1301">Stib&#x0016f;rkov&#x000e1; B, Posp&#x000ed;silov&#x000e1; E, Kmoch S, Sebesta I. Analysis of excretion fraction of uric acid. <span><span class="ref-journal">Nucleosides Nucleotides Nucleic Acids. </span>2006;<span class="ref-vol">25</span>:1301–4.</span> [<a href="/pubmed/17065111" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 17065111</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.turner.2003.1398">Turner JJ, Stacey JM, Harding B, Kotanko P, Lhotta K, Puig JG, Roberts I, Torres RJ, Thakker RV. UROMODULIN mutations cause familial juvenile hyperuricemic nephropathy. <span><span class="ref-journal">J Clin Endocrinol Metab. </span>2003;<span class="ref-vol">88</span>:1398–401.</span> [<a href="/pubmed/12629136" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12629136</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.whiteman.2003.727">Whiteman P, Handford PA. Defective secretion of recombinant fragments of fibrillin-1: implications of protein misfolding for the pathogenesis of Marfan syndrome and related disorders. <span><span class="ref-journal">Hum Mol Genet. </span>2003;<span class="ref-vol">12</span>:727–37.</span> [<a href="/pubmed/12651868" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 12651868</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.wilcox.1996.731">Wilcox WD. Abnormal serum uric acid levels in children. <span><span class="ref-journal">J Pediatr. </span>1996;<span class="ref-vol">128</span>:731–41.</span> [<a href="/pubmed/8648529" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8648529</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.williams.2009.2963">Williams SE, Reed AAC, Galvanovskis J, Antignac C, Goodship T, Karet FE, Kotanko P, Lhotta K, Moriniere V, Williams P, Wong W, Rorsman P, Thakker RV. Uromodulin mutations causing familial juvenile hyperuricaemic nephropathy lead to protein maturation defects and retention in the endoplasmic reticulum. <span><span class="ref-journal">Hum Mol Genet. </span>2009;<span class="ref-vol">18</span>:2963–74.</span> [<a href="/pmc/articles/PMC2714724/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2714724</span></a>] [<a href="/pubmed/19465746" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19465746</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.wolf.2011.181">Wolf MT, Hildebrandt F. Nephronophthisis. <span><span class="ref-journal">Pediatr Nephrol. </span>2011;<span class="ref-vol">26</span>:181–94.</span> [<a href="/pmc/articles/PMC4160028/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC4160028</span></a>] [<a href="/pubmed/20652329" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 20652329</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.wolf.2003.1580">Wolf MT, Mucha BE, Attanasio M, Zalewski I, Karle SM, Neumann HP, Rahman N, Bader B, Baldamus CA, Otto E, Witzgall R, Fuchshuber A, Hildebrandt F. Mutations of the Uromodulin gene in MCKD type 2 patients cluster in exon 4, which encodes three EGF-like domains. <span><span class="ref-journal">Kidney Int. </span>2003;<span class="ref-vol">64</span>:1580–7.</span> [<a href="/pubmed/14531790" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 14531790</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.xu.1997.68">Xu D, Lin SL, Nussinov R. Protein binding versus protein folding: the role of hydrophilic bridges in protein associations. <span><span class="ref-journal">J Mol Biol. </span>1997;<span class="ref-vol">265</span>:68–84.</span> [<a href="/pubmed/8995525" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 8995525</span></a>]</div></li><li class="half_rhythm"><div class="bk_ref" id="mckd2.REF.zivn_.2009.204">Zivn&#x000e1; M, H&#x0016f;lkov&#x000e1; H, Matignon M, Hodanov&#x000e1; K, Vylet'al P, Kalb&#x000e1;cov&#x000e1; M, Baresov&#x000e1; V, Sikora J, Blazkov&#x000e1; H, Zivn&#x000fd; J, Iv&#x000e1;nek R, Str&#x000e1;neck&#x000fd; V, Sovov&#x000e1; J, Claes K, Lerut E, Fryns JP, Hart PS, Hart TC, Adams JN, Pawtowski A, Clemessy M, Gasc JM, G&#x000fc;bler MC, Antignac C, Elleder M, Kapp K, Grimbert P, Bleyer AJ, Kmoch S. Dominant renin gene mutations associated with early-onset hyperuricemia, anemia, and chronic kidney failure. <span><span class="ref-journal">Am J Hum Genet. </span>2009;<span class="ref-vol">85</span>:204–13.</span> [<a href="/pmc/articles/PMC2725269/" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pmc">PMC free article<span class="bk_prnt">: PMC2725269</span></a>] [<a href="/pubmed/19664745" ref="pagearea=cite-ref&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">PubMed<span class="bk_prnt">: 19664745</span></a>]</div></li></ul></div></div><div id="mckd2.Chapter_Notes"><h2 id="_mckd2_Chapter_Notes_">Chapter Notes</h2><div id="mckd2.Author_Notes"><h3>Author Notes</h3><p>Dr Bleyer pursues active clinical research in the area of MCKD. He is forming a registry of individuals with <i>UMOD</i> mutations. In addition, he is most interested in identifying families with the MCKD <a class="def" href="/books/n/gene/glossary/def-item/phenotype/">phenotype</a> who have a mutational analysis that is negative. Please call with any questions about MCKD (336-716-4513).</p><p>Wake Forest University School of Medicine, <a href="http://www.wakehealth.edu/School/Department-of-Nephrology.htm" ref="pagearea=body&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">Section on Nephrology</a></p></div><div id="mckd2.Author_History"><h3>Author History</h3><p>Anthony J Bleyer, MD, MS (2006-present)<br />Karn Gupta, MD; Wake Forest University School of Medicine (2006-2011)<br />P Suzanne Hart, PhD (2011-present)<br />Stanislav Kmoch, PhD (2016-present)</p></div><div id="mckd2.Revision_History"><h3>Revision History</h3><ul><li class="half_rhythm"><div>30 June 2016 (ha) Comprehensive update posted live</div></li><li class="half_rhythm"><div>12 September 2013 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>15 March 2011 (me) Comprehensive update posted live</div></li><li class="half_rhythm"><div>26 September 2007 (cd) Revision: <a class="def" href="/books/n/gene/glossary/def-item/prenatal-diagnosis/">prenatal diagnosis</a> available</div></li><li class="half_rhythm"><div>12 January 2007 (me) Review posted live</div></li><li class="half_rhythm"><div>3 August 2006 (ajb) Original submission</div></li></ul></div></div><div id="bk_toc_contnr"></div></div></div>
            <div class="post-content"><div><div class="half_rhythm"><a href="/books/about/copyright/">Copyright</a> © 1993-2019, University of Washington, Seattle. GeneReviews is
a registered trademark of the University of Washington, Seattle. All rights
reserved.<p class="small">GeneReviews® chapters are owned by the University of Washington. Permission is
hereby granted to reproduce, distribute, and translate copies of content materials for
noncommercial research purposes only, provided that (i) credit for source (<a href="http://www.genereviews.org/" ref="pagearea=meta&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri">http://www.genereviews.org/</a>) and copyright (© 1993-2019 University of
Washington) are included with each copy; (ii) a link to the original material is provided
whenever the material is published elsewhere on the Web; and (iii) reproducers,
distributors, and/or translators comply with the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>. No further modifications are allowed. For clarity, excerpts
of GeneReviews chapters for use in lab reports and clinic notes are a permitted
use.</p><p class="small">For more information, see the <a href="/books/n/gene/GRcopyright_permiss/">GeneReviews® Copyright Notice and Usage
Disclaimer</a>.</p><p class="small">For questions regarding permissions or whether a specified use is allowed,
contact: <a href="mailto:dev@null" data-email="ude.wu@tssamda" class="oemail">ude.wu@tssamda</a>.</p></div><div class="small"><span class="label">Bookshelf ID: NBK1356</span><span class="label">PMID: <a href="/pubmed/20301530" title="PubMed record of this page" ref="pagearea=meta&amp;targetsite=entrez&amp;targetcat=link&amp;targettype=pubmed">20301530</a></span></div><div style="margin-top:2em" class="bk_noprnt"><a class="bk_cntns" href="/books/n/gene/">GeneReviews by Title</a><div class="pagination bk_noprnt"><a class="active page_link prev" href="/books/n/gene/hyper-nfj2/" title="Previous page in this title">&lt; Prev</a><a class="active page_link next" href="/books/n/gene/li-ar/" title="Next page in this title">Next &gt;</a></div></div></div></div>
            
        </div>

        <!-- Custom content below content -->
        <div class="col4">
            
        </div>
        
        
        <!-- Book content -->
        
        <!-- Custom contetnt below bottom nav -->
        <div class="col5">
            
        </div>
    </div>

    <div id="rightcolumn" class="four_col col last">
        <!-- Custom content above discovery portlets -->
        <div class="col6">
            <div id="ncbi_share_book"><a href="#" class="ncbi_share" data-ncbi_share_config="popup:false,shorten:true" ref="id=NBK1356&amp;db=books">Share</a></div>

        </div>
        <div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Views</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PDF_download" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/NBK1356/?report=reader">PubReader</a></li><li><a href="/books/NBK1356/?report=printable">Print View</a></li><li><a data-jig="ncbidialog" href="#_ncbi_dlg_citbx_NBK1356" data-jigconfig="width:400,modal:true">Cite this Page</a><div id="_ncbi_dlg_citbx_NBK1356" style="display:none" title="Cite this Page"><div class="bk_tt">Bleyer AJ, Hart PS, Kmoch S. Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related. 2007 Jan 12 [Updated 2016 Jun 30]. In: Adam MP, Ardinger HH, Pagon RA, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2019. <span class="bk_cite_avail"></span></div></div></li><li><a href="/books/NBK1356/pdf/Bookshelf_NBK1356.pdf">PDF version of this page</a> (788K)</li><li><a href="#" class="toggle-glossary-link" title="Enable/disable links to the glossary">Disable Glossary Links</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>In this GeneReview</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="page-toc" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="#mckd2.Summary" ref="log$=inpage&amp;link_id=inpage">Summary</a></li><li><a href="#mckd2.Diagnosis" ref="log$=inpage&amp;link_id=inpage">Diagnosis</a></li><li><a href="#mckd2.Clinical_Characteristics" ref="log$=inpage&amp;link_id=inpage">Clinical Characteristics</a></li><li><a href="#mckd2.Genetically_Related_Allelic_Disord" ref="log$=inpage&amp;link_id=inpage">Genetically Related (Allelic) Disorders</a></li><li><a href="#mckd2.Differential_Diagnosis" ref="log$=inpage&amp;link_id=inpage">Differential Diagnosis</a></li><li><a href="#mckd2.Management" ref="log$=inpage&amp;link_id=inpage">Management</a></li><li><a href="#mckd2.Genetic_Counseling" ref="log$=inpage&amp;link_id=inpage">Genetic Counseling</a></li><li><a href="#mckd2.Resources" ref="log$=inpage&amp;link_id=inpage">Resources</a></li><li><a href="#mckd2.Molecular_Genetics" ref="log$=inpage&amp;link_id=inpage">Molecular Genetics</a></li><li><a href="#mckd2.References" ref="log$=inpage&amp;link_id=inpage">References</a></li><li><a href="#mckd2.Chapter_Notes" ref="log$=inpage&amp;link_id=inpage">Chapter Notes</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>GeneReviews Links</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="source-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="/books/n/gene/advanced/"><i>GeneReviews</i> Advanced Search</a></li><li><a href="/books/n/gene/glossary/"><i>GeneReviews</i> Glossary</a></li><li><a href="/books/n/gene/resource_mats/">Resource Materials</a> <span class="bk_hlight1">NEW FEATURE</span></li><li><a href="/books/n/gene/updates/">New in <i>GeneReviews</i></a></li><li><a href="/books/n/gene/authors/">Author List</a></li><li><a href="/books/n/gene/prospective_authors/">For Current/Prospective Authors</a></li><li><a href="/books/n/gene/GRpersonnel/"><i>GeneReviews</i> Personnel</a></li><li><a href="/books/n/gene/howto_linkin/">Download/Link to <i>GeneReviews</i></a></li><li><a href="/books/n/gene/contact_us/">Contact Us</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Tests in GTR by Gene</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="document-links" id="Shutter"></a></div><div class="portlet_content"><ul xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="simple-list"><li><a href="https://www.ncbi.nlm.nih.gov/gtr/tests/?term=7369[geneid]" ref="pagearea=document-links&amp;targetsite=external&amp;targetcat=link&amp;targettype=uri&amp;link_id=tests_in_gtr_by_gene">UMOD</a></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Related information</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="discovery_db_links" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=omim&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_omim&amp;IdsFromResult=1472838" ref="log$=recordlinks">OMIM</a><div class="brieflinkpop offscreen_noflow">Related OMIM records</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pmc&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pmc_refs&amp;IdsFromResult=1472838" ref="log$=recordlinks">PMC</a><div class="brieflinkpop offscreen_noflow">PubMed Central citations</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=pubmed&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_pubmed_refs&amp;IdsFromResult=1472838" ref="log$=recordlinks">PubMed</a><div class="brieflinkpop offscreen_noflow">Links to PubMed</div></li><li class="brieflinkpopper"><a class="brieflinkpopperctrl" href="/books/?Db=gene&amp;DbFrom=books&amp;Cmd=Link&amp;LinkName=books_gene&amp;IdsFromResult=1472838" ref="log$=recordlinks">Gene</a><div class="brieflinkpop offscreen_noflow">Locus Links</div></li></ul></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Similar articles in PubMed</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="PBooksDiscovery_RA" id="Shutter"></a></div><div class="portlet_content"><ul><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/21473025" ref="ordinalpos=1&amp;linkpos=1&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease, <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">REN</i>-Related</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease, <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">REN</i>-Related<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Kmoch S, Živná M, Bleyer AJ. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/23946964" ref="ordinalpos=1&amp;linkpos=2&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease, <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MUC1</i>-Related</a><span class="source">[GeneReviews<sup>®</sup>. 1993]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> Autosomal Dominant Tubulointerstitial Kidney Disease, <i xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">MUC1</i>-Related<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Bleyer AJ, Kmoch S. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">GeneReviews®. 1993</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29784615" ref="ordinalpos=1&amp;linkpos=3&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.</a><span class="source">[Am J Kidney Dis. 2018]</span><div class="brieflinkpop offscreen_noflow">Autosomal Dominant Tubulointerstitial Kidney Disease: Clinical Presentation of Patients With ADTKD-UMOD and ADTKD-MUC1.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Ayasreh N, Bullich G, Miquel R, Furlano M, Ruiz P, Lorente L, Valero O, García-González MA, Arhda N, Garin I, et al. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Am J Kidney Dis. 2018 Sep; 72(3):411-418. Epub 2018 May 18.</em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29569962" ref="ordinalpos=1&amp;linkpos=4&amp;log$=relatedreviews&amp;logdbfrom=pubmed"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.</a><span class="source">[Ren Fail. 2018]</span><div class="brieflinkpop offscreen_noflow"><span xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="invert">Review</span> A novel uromodulin mutation in autosomal dominant tubulointerstitial kidney disease: a pedigree-based study and literature review.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lin Z, Yang J, Liu H, Cai D, An Z, Yu Y, Chen T. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Ren Fail. 2018 Nov; 40(1):146-151. </em></div></div></li><li class="brieflinkpopper two_line"><a class="brieflinkpopperctrl" href="/pubmed/29513881" ref="ordinalpos=1&amp;linkpos=5&amp;log$=relatedarticles&amp;logdbfrom=pubmed">Identification of a novel UMOD mutation (c.163G&amp;gt;A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.</a><span class="source">[Braz J Med Biol Res. 2018]</span><div class="brieflinkpop offscreen_noflow">Identification of a novel UMOD mutation (c.163G&amp;gt;A) in a Brazilian family with autosomal dominant tubulointerstitial kidney disease.<div class="brieflinkpopdesc"><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="author">Lopes LB, Abreu CC, Souza CF, Guimaraes LER, Silva AA, Aguiar-Alves F, Kidd KO, Kmoch S, Bleyer AJ, Almeida JR. </em><em xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" class="cit">Braz J Med Biol Res. 2018 Mar 1; 51(3):e6560. Epub 2018 Mar 1.</em></div></div></li></ul><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed_reviews&amp;uid=20301530" ref="ordinalpos=1&amp;log$=relatedreviews_seeall&amp;logdbfrom=pubmed">See reviews...</a><a class="seemore" href="/sites/entrez?db=pubmed&amp;cmd=link&amp;linkname=pubmed_pubmed&amp;uid=20301530" ref="ordinalpos=1&amp;log$=relatedarticles_seeall&amp;logdbfrom=pubmed">See all...</a></div></div><div class="portlet"><div class="portlet_head"><div class="portlet_title"><h3><span>Recent Activity</span></h3></div><a name="Shutter" sid="1" href="#" class="portlet_shutter" title="Show/hide content" remembercollapsed="true" pgsec_name="recent_activity" id="Shutter"></a></div><div class="portlet_content"><div xmlns:np="http://ncbi.gov/portal/XSLT/namespace" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" id="HTDisplay" class=""><div class="action"><a href="javascript:historyDisplayState('ClearHT')">Clear</a><a href="javascript:historyDisplayState('HTOff')" class="HTOn">Turn Off</a><a href="javascript:historyDisplayState('HTOn')" class="HTOff">Turn On</a></div><ul id="activity"><li class="ra_rcd ralinkpopper two_line"><a class="htb ralinkpopperctrl" ref="log$=activity&amp;linkpos=1" href="/portal/utils/pageresolver.fcgi?recordid=5e042b9775f66d18aa1ef998">Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related - GeneReviews...</a><div class="ralinkpop offscreen_noflow">Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related - GeneReviews®<div class="brieflinkpopdesc"></div></div><div class="tertiary"></div></li></ul><p class="HTOn">Your browsing activity is empty.</p><p class="HTOff">Activity recording is turned off.</p><p id="turnOn" class="HTOff"><a href="javascript:historyDisplayState('HTOn')">Turn recording back on</a></p><a class="seemore" href="/sites/myncbi/recentactivity">See more...</a></div></div></div>
        
        <!-- Custom content below discovery portlets -->
        <div class="col7">
            
        </div>
    </div>
</div>

<!-- Custom content after all -->
<div class="col8">
    
</div>
<div class="col9">
    
</div>

<script type="text/javascript" src="/corehtml/pmc/js/jquery.scrollTo-1.4.2.js"></script>
<script type="text/javascript">
    (function($){
        $('.skiplink').each(function(i, item){
            var href = $($(item).attr('href'));
            href.attr('tabindex', '-1').addClass('skiptarget'); // ensure the target can receive focus
            $(item).on('click', function(event){
                event.preventDefault();
                $.scrollTo(href, 0, {
                    onAfter: function(){
                        href.focus();
                    }
                });
            });
        });
    })(jQuery);
</script>
                        </div>
                        <div class="bottom">
                            
                            <div id="NCBIFooter_dynamic">
    <a id="help-desk-link" class="help_desk" href="" target="_blank">Support Center</a>
    <a id="help-desk-link" class="help_desk" href="https://support.ncbi.nlm.nih.gov/ics/support/KBList.asp?Time=2019-12-25T22:40:07-05:00&amp;Snapshot=%2Fprojects%2Fbooks%2FPBooks@5.22&amp;Host=portal104&amp;ncbi_phid=CE8BED70E0418A710000000008A6033F&amp;ncbi_session=CE8BED70E042B961_2214SID&amp;from=https%3A%2F%2Fwww.ncbi.nlm.nih.gov%2Fbooks%2FNBK1356%2F&amp;Db=pmc&amp;folderID=134&amp;Ncbi_App=bookshelf&amp;Page=literature&amp;style=classic&amp;deptID=28049" target="_blank">Support Center</a>
    
</div>

                            <div class="footer" id="footer">
    
    <div class="subfooter"> </div><script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/preloaderWidget.js"> </script>
    <div id="external-disclaimer" class="offscreen_noflow">
        External link. Please review our <a href="https://www.nlm.nih.gov/privacy.html">privacy policy</a>.
    </div>    
    <div id="ncbifooter" class="contact_info">      
        <div id="footer-contents-right">
            <div id="nlm_thumb_logo">
                <a href="https://www.nlm.nih.gov" title="NLM">NLM</a>
            </div>
            <div id="nih_thumb_logo">
                <a href="https://www.nih.gov" title="NIH">NIH</a>
            </div>
            <div id="hhs_thumb_logo">
                <a href="https://www.hhs.gov" title="DHHS">DHHS</a>
            </div>
            <div id="usagov_thumb_logo">
                <a href="https://www.usa.gov" title="USA.gov">USA.gov</a>
            </div>         
        </div>
        
        <div id="footer-contents-left">
            <p class="address vcard">
                <span class="url">
                    <a class="fn url newdomain" href="https://www.ncbi.nlm.nih.gov">National Center for
                        Biotechnology Information</a>,
                </span> <span class="org url newdomain"><a href="https://www.nlm.nih.gov/">U.S. National Library of Medicine</a></span>
                <span class="adr">
                    <span class="street-address">8600 Rockville Pike</span>, <span class="locality">Bethesda</span>
                    <span class="region">MD</span>, <span class="postal-code">20894</span>
                    <span class="country-name">USA</span>
                </span>
            </p>
            
            <a href="/home/about/policies.shtml">Policies and Guidelines</a> | <a href="/home/about/contact.shtml">Contact</a>
        </div>
    </div>
    <script type="text/javascript" src="/portal/portal3rc.fcgi/rlib/js/InstrumentOmnitureBaseJS/InstrumentNCBIConfigJS/InstrumentNCBIBaseJS/InstrumentPageStarterJS.js?v=1"> </script>    
    <script type="text/javascript" src="/portal/portal3rc.fcgi/static/js/hfjs2.js"> </script>
</div>
                        </div>
                    </div>
                    <!--/.page-->
                </div>
                <!--/.wrap-->
            </div><!-- /.twelve_col -->
        </div>
        <!-- /.grid -->

        <span class="PAFAppResources"></span>
        
        <!-- BESelector tab -->
        
        
        
        <noscript><img alt="statistics" src="/stat?jsdisabled=true&amp;ncbi_db=books&amp;ncbi_pdid=book-part&amp;ncbi_acc=NBK1356&amp;ncbi_domain=gene&amp;ncbi_report=record&amp;ncbi_type=fulltext&amp;ncbi_objectid=&amp;ncbi_pcid=/NBK1356/&amp;ncbi_pagename=Autosomal Dominant Tubulointerstitial Kidney Disease, UMOD-Related - GeneReviews® - NCBI Bookshelf&amp;ncbi_bookparttype=chapter&amp;ncbi_app=bookshelf" /></noscript>
        
        
        <!-- usually for JS scripts at page bottom -->
        <!--<component id="PageFixtures" label="styles"></component>-->
    

<!-- CE8BED70E042B961_2214SID /projects/books/PBooks@5.22 portal104 v4.1.r585844 Mon, May 06 2019 02:53:16 -->

<script type="text/javascript" src="//static.pubmed.gov/portal/portal3rc.fcgi/4176521/js/3879255/4121861/3501987/4008961/3893018/3821238/4062932/4123007/4087685/4076480/3921943/3400083/3426610.js" snapshot="books"></script></body>
</html>